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                                                        Abstract 
  
In eukaryotic cells, vesicular trafficking plays significant roles in exocytosis, 
endocytosis and cell component recycling. Vesicular trafficking includes vesicle 
budding, targeting, docking and fusion with the targeting apparatus. Small GTPases 
are involved in all stages of vesicular trafficking by recruiting their effectors. This 
thesis focuses on two small GTPases, Arl1 and Rab7, and their respective effectors, 
the Golgins containing GRIP domain and the Rab-interacting lysosomal protein 
(RILP). The aims of these two projects are to investigate the molecular mechanism by 
which Arl1 and Rab7 recruit their respective effectors by X-ray crystallography. 
 The structure of the Arl1-GRIP domain complex showed that the GRIP 
domain consisting of three twisted helices forms a tight homodimer with each subunit 
binding to one Arl1-GTP on opposite sides respectively. Arl1-GTP interacts with 
helices α1 and α2 of GRIP domain predominantly in a hydrophobic manner with the 
switch II region conferring the main recognition surface. The involvement of the 
switch and the interswitch regions in the Arl1-GTP:GRIP domain interaction explains 
the specificity of GRIP domain for Arl1-GTP. The most significant finding is that 
GRIP domain is a homodimer with all three α-helices involved in dimerization. Based 
on structural data, functional studies on the GRIP domain showed that mutations 
disrupting the GRIP domain dimerization also abrogated their Golgi targeting, 
strongly suggesting that the dimeric form of the GRIP domain is a functional unit. 
 In the structure of Rab7-RILP effector domain complex, Rab7 interacts with 
RILP specifically via two distinct areas, with the first one involving the switch and 
interswitch regions, and the second one consisting of the hypervariable regions 
 vi
 vii
RabSF1 and RabSF4. Disruption of these interactions by mutations abrogates the late 
endosomal/lysosomal targeting of Rab7 and RILP. The Rab7 binding domain of RILP 
forms a coiled-coil homodimer with two symmetric surfaces to interact with two 
separate Rab7-GTP molecules, forming a dyad configuration of Rab7-RILP2-Rab7. 
Mutations that disrupt RILP dimerization also abolish their interactions with Rab7-
GTP and the late endosomal/lysosomal targeting, suggesting that RILP functions as a 
dimer in cells. Structural comparison suggests that the combined use of RabSF1 and 
RabSF4 with the switch regions may be a general mode of action for Rab proteins in 
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                                 Chapter 1 Introduction  
1.1  Vesicular trafficking  
   Eukaryotic cells need to take up nutrients, recycle membrane, defend against 
invading microbes and communicate with the cells outside. The nutrients, membrane 
components and microbes are taken up by the process of endocytosis. These 
molecules are ingested into vesicles derived from the plasma membrane and delivered 
to early endosomes and then (via late endosomes) to the lysosome for digestion. The 
internal membrane allows cells to regulate the delivery of newly synthesized proteins, 
carbohydrates and lipids to different organelles in the biosynthetic-secretory pathway. 
The molecules are sorted and transported from the endoplasmic reticulum (ER) to the 
Golgi apparatus and then to other organelles such as endosomes and the lysosome. To 
form and maintain the membrane identity of organelles, many endocytosed molecules 
or membrane components are retrieved from early endosomes and returned to the cell 
surface for reuse. Similarly, molecules and membrane components are retrieved from 
the late endosome and returned to the Golgi apparatus or the ER. The exocytosis, 
endocytosis and recycling are performed by intracellular vesicle trafficking by 
transport vesicles (Alberts et al., 2002).  
There are at least four steps in the intracellular vesicle trafficking: vesicle 
budding from the donor membrane, vesicle targeting to the destination membrane, 
vesicle docking to the acceptor membrane and vesicle fusion with the targeted 
membrane (Figure 1-1a).  The initial formation of the donor membrane requires the 
assembly of specific proteins coating the cytoplasmic face of the donor membrane, 
which provides the mechanical force to pull the membrane into a bud and help to 
capture specific membrane receptors and cargo proteins. There are three classes of 
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coated vesicles in the cell: clathrin-, COPI- and COPII-coated vesicles. Clathrin-
coated vesicles mediate the protein transport from the cell surface through 
compartments of the endocytic pathway, as well as the protein transport from the 
trans Golgi network (TGN) to lysosomal/vacuolar compartments and terminal 
compartments of the regulated secretory pathway. COPI-coated vesicles are involved 
in the membrane trafficking from the Golgi apparatus back to the ER. COPII-coated 
vesicles are involved in the export of cargo molecules from the ER to the Golgi 
apparatus. GTPases, Sar1 and ADP-ribosylation factor (Arf) proteins, play crucial 
roles in the membrane recruitment of the COPII and COPI components, respectively 
(Nuoffer and Balch, 1994). The clathrin-coated vesicle is well studied and used as an 
example here to show how the vesicle forms. Adaptin, a multisubunit complex, binds 
clathrin or other coats to the membrane and traps various transmembrane proteins 
including receptors that capture cargo molecules. Adaptin allows the cargo molecules 
to be packed into the newly formed coated transport vesicle. As a clathrin-coated bud 
grows, other cytosolic proteins including dymanin, a GTPase, assemble around the 
neck of each bud to regulate the rate of the bud pinching-off to form a vesicle. With 
the help of these proteins around the neck, the two noncytosolic leaflets of the 
membrane are brought close to each other, fuse and then pinch off to form the vesicle 
(Figure 1-1b) (Alberts et al., 2002).  
After budding from the donor membrane, the coat proteins and GTPases are 
disassembled and recycled to form new vesicles. The vesicles containing the cargo 
molecules are transported toward the target membrane, then dock and fuse with it.  
The tethering step is defined as the initial contact of the vesicle via a protein bridge 
with its target compartment and is the critical determinant for the specificity of 
membrane fusion. The tethering complexes must be formed to target on the cognate 
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compartment. There are several tethering factors that function in this process. The 
long coiled-coil proteins and seven large conserved protein complexes including the 
exocyst, the conserved oligomeric Golgi (COG), the Golgi-associated retrograde 
protein (GARP), the  transport protein particles (TRAPP I and TRAPP II), the class C 
Vps and the Dsllp have been identified as potential tethering factors. These tethering 
factors lie in the upstream or downstream pathway of the activation of Rab GTPases 
or Arf-like (Arl) proteins, thus conferring the specificity of vesicle recognition at the 
earliest stage of membrane fusion (Whyte and Munro, 2002; Lupashin and Sztul, 
2005). Two soluble NSF (N-ethylmaleimide sensitive factor) attachment receptors 
(SNAREs), named v-SNARE associated with the vesicle compartment and t-SNARE 
associated with the target compartment, interact with each other, resulting in the 
docking and fusion with the target membrane. The specific interaction of v-SNARE 
on the transport intermediate with its cognate t-SNARE on the target compartment 
underlies the central event of docking and fusion of vesicle-mediated transport. This 
interaction between v-SNARE and t-SNARE leads to form the trans-SNARE 
complex (or SNAREpin). The structure of the trans-SNARE complex is a twisted 
parallel four-helix bundle, in which v-SNARE contributes one helix and t-SNAREs 
provide the other three. The formation of the four-helix structure catalyzes the 
apposition and fusion of the vesicle with the target compartment (Figure 1-1c and 1-
1d). In addition, other proteins or other SNARE regulators are required for the 
process of docking and fusion. Rab GTPases provide the specificity for SNARE 
complexes to dock and fuse with the target membrane. After fusion, the trans-SNARE 
complex becomes a cis-SNARE complex in the target compartment. The cis-SNARE 
complex is then disassembled and recycled for the next round of docking and fusion. 
This is catalyzed by α-SNAP (soluble N-ethylmaleimide-sensitive factor attachment 
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protein) and NSF which is an ATPase (Weber et al., 1998; Sutton et al., 1998; 
Antonin et al., 2002; Hong, 2005).  
As described above, the GTPases, such as Arf proteins and Rab GTPases, play 
vital roles in all stages of the vesicular trafficking. The involvement of the GTPases in 
vesicle trafficking has been well discussed (Nuoffer et al., 1994; Rothman, 1994; 
Takai et al., 2001; Zerial and McBride, 2001). The following part of this introduction 
will focus on the GTP-binding proteins (G proteins) and more specifically on the 
small GTP-binding proteins, Ras superfamily.  
 
1.2 GTP-binding proteins (G proteins) 
G proteins are regulatory GTP hydrolases. They include Ras and its close 
homologs (Ras superfamily), protein synthesis factors (elongation factors, EF-Tu, G), 
heterotrimeric G proteins, the signal recognition particle (SRP) and the SRP receptor 
(SR), and other proteins containing a GTP-binding domain, such as dynamin. By their 
oligomeric states, G proteins can be classified into heterotrimeric and monomeric 
GTPases. Monomeric GTPases can be further divided into large GTPases, such as 
dynamin and protein synthesis factors, and small GTPases, Ras superfamily. Protein 
synthesis factors (EFs) ensure the fidelity of mRNA translation in the ribosome. 
Heterotrimeric G proteins containing Gα, Gβ, and Gγ subunits have been well studied 
to transduce extracellular signals to intercellular effectors through coupling with 
transmembrane receptors (Kaziro et al., 1991). SRP and SR mediate the 
cotranslational targeting of secreted and membrane proteins to the ER membrane in 
mammalian cells and to the plasma membrane in bacteria (Keenan et al., 2001). The 
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c.                                                                    d.  
                                               
Figure 1-1. Intracellular vesicular traffic (Adapted from Alberts et al., 2002) 
a. Vesicular transport. Transport vesicles bud from one compartment, transport cargo 
molecules to the target compartment, dock and fuse with the target compartment.  
b. The budding of clathrin-coated vesicle. The assembly of the coat introduces 
curvature into the membrane to form coated buds. The adaptins and membrane-bound 
receptors selectively recruit cargo molecules in
lp it pinch off to form
dly after the vesicle forms.  
ity of 
5 is a peripheral membrane protein that 
contributes two helices to form a twisted parallel four-helix bundle.                      
   
to vesicles. Dynamin around the neck 
 a vesicle. The coat of clathrin-coated vesicles is 
                 
of the bud he
removed rapi
c. Complementary sets of v-SNAREs and t-SNAREs contribute to the selectiv
transport-vesicle docking and fusion. Different v-SNAREs are packaged with 
different cargo molecules in vesicles targeting different compartments. The v-
SNAREs bind to complementary t-SNAREs to fulfill docking and fusion with target 
compartments. 
d. The structure of synaptic trans-SNARE complex. The SNAREs responsible for 
docking synaptic vesicles contain three proteins. v-SNARE (Synaptobrevin) and the t-
SNARE Syntaxin are both transmembrane proteins and each contributes one α-helix 
to the complex. The t-SNARE Snap2
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  The structures of many G proteins have been solved. The structures to date 
demonstrate that all members of this group share a common structural core (G 
domain), exemplified by that of p21ras (Ras), except SRP and its receptor SR, in 
ilar
Bhattacharya et al., 2004). The rest of the introduction will focus on the largest family 
which the G domains show a divergent topology of the β sheet in addition to an 
extension and insertion (Sprang, 1997; Vetter and Wittinghofer, 2001). The structural 
sim ity, reflected in significant sequence identity, suggests a common evolutionary 
origin for these proteins (Bourne et al., 1990; Bourne et al., 1991). G proteins have a 
conserved recognition site for guanine nucleotides, although they have different 
mechanisms of GTP hydrolysis. In all G proteins, binding and hydrolysis of GTP 
trigger reciprocal conformational changes in the switch regions within the catalytic 
domain. The GTP- and GDP-bound complexes define, respectively, the active and 
inactive states of a G protein as a regulatory molecule. The transition between active 
and inactive states may be limited by the intrinsic rate of GTP hydrolysis, or it may be 
accelerated by the binding of a GTPase-activating protein (GAP) or by the association 
of the G protein with a particular conformational state of its effectors. Thus, the G 
proteins include clocks (heterotrimeric G protein α subunits), switches or adapters 
(Ras superfamily), and sensors (EF-Tu and G). Guanine nucleotide dissociation 
inhibitors (GDIs) inhibit the release of GDP from certain G proteins, whereas guanine 
nucleotide exchange or release factors (GEFs or GRFs) stimulate this process.  The 
mechanisms of G protein activities and regulations are well understood due to a 
number of structural analyses (Sprang, 1997).  
Heterotrimeric G proteins have also been shown to be involved in membrane 
traffic including a cross-talk with small monomeric GTPases in different stages in the 
intracellular vesicular traffic (Bomsel and Mostov, 1992; Nuoffer et al., 1994; 
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of G proteins, the Ras superfamily, which are involved directly in the different stages 
of intracellular vesicular traffic. 
 
 
1.3 Ras superfamily 
1.3.1  Ras superfamily 
The Ras superfamily, also called small GTPases below, are the monomeric 
GTP-binding proteins with molecular masses of 20-40 kDa. To date, more than 150 
members of this superfamily have been identified in eukaryotes from yeast to human 
(Takai  al., 2001; Wennerberg et al., 2005). According to their primary sequences, 
 biochemical properties, the members of the Ras superfamily 
 5 families: Ras, Rho, Rab, Arf and Ran (Figure 1-2). These 
small G
 contain a 13-amino-acid α-helix 
sertion in the core domain. Arf proteins contain an N-terminal extension while Rab 
roteins contain a C-terminal extension. The extensions are necessary for insertion 
oteins have an elongated C-terminal  
et
structural features and
have been classified into
TPases share a common biochemical mechanism and act as binary molecular 
switches. They play major roles in the regulation of cell growth, transformation, 
morphogenesis, cell motility, cytokinesis, intracellular vesicular traffic, and nuclear 
protein transport (Exton, 1998; Vetter et al., 2001). 
 
 
1.3.2  Tertiary structures 
   The core of small G proteins, called the G domain, is the guanine nucleotide-
binding domain, which is around 200 residues and consists of a central six-strand β-
sheet surrounded by α-helices.  The Rho proteins
in
p










lement crucial for its function in nuclear protein transport (Vetter et al., 2001). All 
ific interactions with guanine nucleotides, GDP and GTP. Structurally, there 
re five loops that form the guanine nucleotide binding sites. The five loops are 
esignated G1 through G5 from the N-terminus. The G1 box with the consensus 
quences, GXXXXGK(S/T), contacts the α- and β-phosphates of the guanine 
e





nucleotides. The G2 box contains a conserved Thr residue involved in the 
coordination of Mg2+ (Walker et al., 1982). The G3 box, DXXGQ, is responsible for 
the binding of the γ-phosphate of GTP and Mg2+. The guanine nucleotide ring is 
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partly recognized by the G4 box, NKXD, and by the G5 box, (T/G)(C/S)A (Figures 
1-3 and 1-4). By comparing the structures of the GTP-bound conformation and the 
GDP-bound conformation, two highly flexible regions surrounding the γ-phosphate of 
GTP have been established: the switch I region within loop L2 and β2 and the switch 
II region within L4 and helix α2. The conformations of these two regions change 
dramatically upon the GTP hydrolysis to GDP (Figure 1-4) (Sprang, 1997; Takai et 








Figure 1-3. The guanine nucleotide binding sites of Ras in the GppCp·Mg2+ 
complex. Side chains of the highly conserved G-box residues are darkened and 







           
 
           
 
Figure 1-4. A schematic diagram of Ras. Switch segments are darkened, secondary 
structure elements and G-box regions are labeled. Top: The GppCp · Mg2+ complex, 
coordinates taken from Protein Databank (PDB) entry 5P21. The nonhydrolyzable 
nalog is depicted by a ball-and-stick model. The single solid sphere represents 






  Knowledge of the relationship between the structure and function of small 
GTPases has made it possible to design GTPase mutants with altered guanine 
nucleotide binding affinity and specificity or hydrolytic activity. In general, 
substitution of Ala for Ser (Thr) in the G1 box, GXXXXGK(S/T), increases the 
affinity of the GTPase for GDP, thus resulting in a dominant-negative mutant. On the 
other hand, substitution of the highly conserved glutamine for leucine in G3 box, 
DXXGQ, abolishes the GTP hydrolysis activity of GTPase and locks the small 
GTPase in its active form, resulting in a dominant-positive mutant (Zhong et al., 1995; 
ittinghofer and Valencia, 1995). 
duce an upstream signal to a downstream 
et al., 2001). 
 Release of GDP from the GDP-bound form is extremely slow and is the rate-




1.3.3 Molecular switches and regulations 
   Structural and biochemical studies of small GTPases showed that there are 
two interconvertible forms of small GTPases: a GDP-bound inactive form and a GTP-
bound active form. In the GDP-bound form, small GTPases can not bind their 
effectors. The conformational change then occurs when the GDP is replaced by GTP, 
which allows the small GTPases to bind the downstream targets. The GTP-bound 
form is converted by the intrinsic GTPase activity or GTPase-activating proteins 
(GAPs) to the GDP-bound form, which then releases the bound downstream effectors. 
In this way, one cycle of activation and inactivation is achieved, and small G proteins 
serve as molecular switches that trans
effector (Takai 
  
limiting step of the GDP/GTP exchange
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nucleotide exchange factor (GEF) or guanine nucleotide exchange protein (GEP), 
stimulates this reaction. By increasing the rate of GDP release, GEF stimulates the 
conformational changes required for activation. The GDP/GTP exchange reactions of 
the Rho and Rab proteins are further regulated by another type of regulator, named 
Rho GDP-dissociation inhibitor (RhoGDI) or Rab GDP-dissociation inhibitor 
(RabGDI) (Figure 1-5). GDIs bind the GDP-bound form of small GTPases and 
function as negative regulators by inhibiting both the basal and GEF-stimulated 
dissociation of GDP. Therefore, they keep the small G proteins in the inactive form. 
RhoGDIs and RabGDIs show wider substrate specificity than GEPs and GAPs. The 
intrinsic GTPase activities of small G proteins are variable but all are relatively slow 
and are stimulated by GAPs. Most GAPs are specific for each member or subfamily 
of small GTPases, but some GAPs show wider substrate specificity (Takai et al., 
2001).     
 
                
 





1.3.3.1 GTP hydrolysis and GAPs 
    The mechanism of GTP hydrolysis by small GTPases is well researched via 
biochemical and structural studies (Sprang, 1997; Li and Zhang, 2004). Generally, a 
highly conserved glutamine in the switch II region is considered to be the key 
catalytic residue of small GTPases. The side chain of glutamine plunges into the GTP-
binding pocket and repositions a water molecule for nucleophilic attack. However, 
this glutamine is not in a proper conformation for nucleophilic attack and needs 
adjustment to position correctly the nucleophilic water molecule to attack the γ-
, thus leading to the low intrinsic GTPase activity. Mutation of the catalytic 
lutamine in small GTPases completely abolishes the GTP hydrolysis activity and 
ses, which are helpful to study the characteristics of small GTPases and 
trimeric G protein, an arginine in the G 
phosphate
g
keeps them in the active form. This has allowed the creation of the constitutive active 
all GTPasm
their downstream effectors. In the hetero
protein stabilizes the negative charge of the γ-phosphate of GTP and helps the 
glutamine position the water molecule for nucleophilic attack, thus stimulating the 
hydrolysis of GTP (Sprang, 1997). The lack of this catalytic residue in all small 
GTPases causes the low intrinsic GTPase activity.  
   As described above, GAPs stimulate the GTP hydrolysis and inactivate small 
GTPases. Structures of RasGAP, RhoGAP and RanGAP have been solved (Scheffzek 
et al., 1997; Rittinger et al., 1997a; Rittinger et al., 1997b; Wurtele et al., 2001; 
Seewald et al., 2002). The structures of Ras-RasGAP and RhoA-RhoGAP complexes 
demonstrate how GTP hydrolysis by small GTPases is stimulated by GAPs. The 
GTPase-GAP complexes undergo conformational changes to bring the arginine of 
GAPs to activate the hydrolysis of GTP. The arginine, which is called the arginine 
finger, is conserved in some GAPs.  The GAPs provide the arginine in trans, in 
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contrast to heterotrimeric G proteins which provide the arginine in cis, to stabilize the 
glutamine in the switch II region and correct the positioning of the nucleophilic water 
molecule to stimulate GTP hydrolysis (Scheffzek et al., 1997). The general 
mechanism that GAPs provide the catalytic trans-arginine finger seems to be shared 
ate a subset of Rab proteins 
urton et al., 1997). Most GEFs are specific for each member or subfamily of small 
by GAPs. However, the recent structure of Rap1GAP which lacks of the trans-
arginine showed that an asparagine but not arginine was absolutely essential for 
catalysis (Daumke et al., 2004). Therefore, the “asparagine thumb” may have a 
similar function to the arginine finger provided by RasGAP and RhoGAP. In contrast, 
RanGAP used a tyrosine instead of an arginine (Seewald et al., 2002). The structure 
of the GAP domain of rna1p, a RanGAP, suggested that it could provide a lysine 
residue for the catalysis (Hillig et al., 1999). This indicates that GAPs may have more 
divergent mechanisms for stimulating GTP hydrolysis. 
 
 
1.3.3.2 Nucleotide exchange by GEF 
GEF catalyzes the dissociation of GDP from the inactive form of small 
GTPases and replaces the GDP with GTP. GTP binding induces the conformational 
changes, thus causing the dissociation of GEF from small GTPases and activating the 
small GTPases to allow the interaction with downstream effectors. There are many 
varieties of GEFs of small GTPases. Small GTPases are recognized by one or more 
homologs of a distinct and corresponding family of GEFs. Rho proteins are substrates 
of GEFs that contain tandem Dbl homology (DH) domains.  GEFs of Ras, Ral and 
Rap contain a domain homologous to that in the CDC25 protein. GEFs containing a 




GTPases, but some GEFs show wider substrate specificity (Sprang, 1997; Takai et al., 
   
lical proteins (Renault et al., 1998; Renault et al., 2001).  The structures of 
ple
2001). 
The reaction of nucleotide exchange includes several stages. GEFs first 
interact and form a low affinity docking complex with the GDP-bound G protein 
(Klebe et al., 1995). GDP then dissociates from this complex, which becomes a 
binary GEF-small-G-protein complex with high affinity for GTP. GTP then binds the 
G protein and the GEF dissociates from this complex (Lai et al., 1993).  The 
mechanism of nucleotide exchange by GEF is also well studied (Sprang, 1997; 
Sprang and Coleman, 1998; Cherfils and Chardin, 1999). Several structures of GEF 
domains have been determined (Boriack-Sjodin et al., 1998; Goldberg, 1998; Renault 
et al., 1998; Liu et al., 1998; Soisson et al., 1998). The catalytic domains of the 
different classes of GEFs share no sequence homology and are structurally unrelated. 
For example, RCC1, the GEF for Ran, adopts a β-propeller fold while other GEFs are 
all α-he
com xes of Ras with the CDC25 domain of SOS and of Arf1 with the Sec7 domain 
have been reported (Boriack-Sjodin et al., 1998; Goldberg, 1998). These two 
structures form the basis of our current understanding of the mechanism of how GEFs 
stimulate nucleotide exchange.  In the Ras-CDC25 structure, a glutamic acid is 
inserted into the phosphate-Mg2+ binding site. Therefore, the phosphate-binding loop 
(P-loop) is distorted into a conformation that is not compatible with the binding of 
GDP (Boriack-Sjodin et al., 1998). In the Arf1-Sec7 structure, a glutamic acid in the 
Sec7 domain is also used to distort the P-loop into a conformation that prevents the 
binding of β-phosphate of GDP (Goldberg, 1998). In both structures, the 
conformations of the switch regions and the P-loop are different from the GDP- and 
GTP-bound small GTPase structures (Cherfils et al., 1999).  
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The glutamic acid residue is invariant in Sec7 domains but not conserved in all 
CDC25 domains. In RCC1, an asparate residue may have the similar function as the 
glutamic acid in the Sec7 or CDC25 domains. Threonine or serine residues, but not a 
glutamic acid residue, seem to be necessary for the catalysis by the DH domain 
(Aghazadeh et al., 1998). Although a glutamic acid is not used by all GEFs to distort 
the P-loop, these structures of GEF-GTPase complexes and biochemical data suggest 
that GEFs stimulate the nucleotide exchange of small GTPases using a “glutamate 
finger” or using other catalytic residues that have a similar function. The interaction 
between GEF and small GTPase also causes the large conformational changes in 
switch regions, which contribute to stabilize the conformations of the altered P-loop 
and the nucleotide-free protein. Thus, a GTP molecule can bind the exposed GTP-
binding site of the small GTPase (Cherfils et al., 1999). 
 
 
1.3.3.3 Guanine dissociation inhibitor (GDI) 
   GDI binds GDP-bound small GTPases and inhibits the GDP release, thus 
functioning as negative regulator to prevent the activation of small GTPases. Small 
GTPases are commonly found to cycle between membrane and cytosol pools, which 
is prerequisite for their functions. However, for Rab and Rho proteins, the highly 
hydrophobic geranylgeranyl moieties at their C termini prevent their release into the 
cytosol as individual monomers while other small GTPases can be in the cytosol for 
the moderate hydophobicity of the lipid modification. GDI can bind lipid-modified 
Rho or Rab proteins and extract them from the membrane, keeping them in the 
cytosol (Takai et al., 2001). 
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   Structural studies have been carried out to elucidate how GDI binds small 
he structure of Rac-RhoGDI complex 
GDI had already defined two important domains within 
GTPases and inhibits the dissociation of GDP. T
showed that RhoGDI inhibited the GDP dissociation by stabilizing the switch I-
supported Mg2+ binding in the GDP-bound comformation. The switch II region, 
which is not involved in the GDP binding, did not contribute to the interaction.  This 
suggests that, for inhibition of guanine nucleotide dissociation, RhoGDI stabilizes 
Mg2+ binding by Rho proteins without blocking the access to the nucleotide binding 
pocket (Scheffzek et al., 2000). However, this structure does not show how RhoGDI 
interacts with the isoprenylation moiety at the C terminus of Rho proteins. Structural 
studies on RabGDI provide us more details on the mechanism of the inhibition by 
GDIs. Earlier studies on Rab
RabGDI: a Rab-binding platform and the mobile effector loop (MEL), a region 
implicated in membrane interaction (Luan et al., 2000; Alory and Balch, 2001). Two 
crystal structures of RabGDI complexes have been determined. The first study used a 
geranylgeranyl moiety linked to a single cysteine as a model binding partner (An et 
al., 2003). The geranylgeranyl ligand was bound in a shallow hydrophobic groove on 
the surface of RabGDI and induced a conformational change in the MEL, which is 
proposed to result in the release of RabGDI:Rab complexes from the membrane. The 
crystal structure of yeast RabGDI complexed with mono-prenylated Ypt1 which was 
generated using the elegant approach to ligate a chemically synthesised lipidated 
peptide to a recombinant Rab, revealed a different location for the geranylgeranyl-
binding site in RabGDI (Rak et al., 2003). The lipid is accommodated in a deep 
hydrophobic cavity within the core of the α-helical domain II of the protein. This 
cavity appears to result from the conformational changes in RabGDI, induced by 
interactions with the switch regions and the C terminus of the Rab protein, suggesting 
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a biphasic model for the extraction of the first geranylgeranyl group from the 




1.3.4 Localization and lipid modification  
   Most small GTPases are localized either in the cytosol or on the membrane. 
Generally, the GTP-bound active state of small GTPases is localized on the 
membrane while the GDP-bound inactive state of small GTPases is cytosolic. An 
exception is Ran, which is localized either in the cytosol or in the nucleus. It is 
translocated between the cytosol and the nucleus through the nuclear pore complex 
(NPC). Post-translational lipid modification is important for most of small GTPases 
and is necessary for their binding to the membrane and regulators and for their 
activation of downstream effectors. The lipid moieties and some specific residues on 
e small GTPases interact with lipids on the membrane to localize the small GTPases 
ere (Takai et al., 2001). The majority of Ras and Rho proteins terminate with a C-
y amino acid) tetrapeptide sequence (Cox 
th
th
terminal CAAX (C=Cys, A=aliphatic, X=an
and Der, 2002). This motif, when coupled together with other residues, such as 
cysteine residues modified by the fatty acid palmitate, comprises the membrane-
targeting sequences that dictate interactions with distinct membrane compartments 
and subcellular locations. The CAAX motif is the recognition sequence for 
farnesyltransferase and geranylgeranyltransferase I, which catalyze the covalent 
addition of a farnesyl or geranylgeranyl isoprenoid, respectively, to the cysteine 
residue in the tetrapeptide motif. Rab proteins terminate in a distinct set of cysteine-
containing C-terminal motifs (CC, CXC, CCX, CCXX, or CCXXX) that are similarly 
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modified by geranylgeranyltransferase II, which also attaches geranylgeranyl groups 
(Takai et al., 2001; Wennerberg et al., 2005). Arf and Arl proteins are modified at 
their amphipathic N-terminal helix by a myristate fatty acid while Sar1 interacts with 
the phospholipids through only the peptide region (Antonny et al., 1997; Takai et al., 
2001). Some small GTPases such as Rit, RhoBTB and Miro do not appear to be 
modified by lipids, but still associated with the membrane. Others like Ran and Rerg 
are not lipid modified and are not bound to membranes (Wennerberg et al., 2005). 
 
 
1.3.5 Functional and structural studies of Ras-like superfamily 
1.3.5.1 Ras family 
 The Ras family includes Ras, Rap, Ral as well as other related subfamilies 
such as Rad/Kir/Gem and RheB (Takai et al., 2001; Colicelli, 2004). The rat sarcoma 
(Ras) oncogenes were the founding members of the Ras superfamily and have been 
the subject of intense research because of their critical roles in human oncogenesis. As 
well as oncogenesis, Ras proteins play key roles in cellular proliferation, 
differentiation and survival via cytoplasmic signaling networks that respond to diverse 
extracellular stimuli such as growth factors, cytokines and hormones. The best 
haracterized Ras effector signalling pathway is the interaction and activation of Rafs, 
ading to the stimulation of the mitogen-activated protein kinase (MAPK) cascade 
ic targets are 
 translocated to the nucleus, thus stimulating the activities of 
c
le
(Repasky et al., 2004). Through this pathway, the cytoplasm
phosphorylated and
various transcription factors. Like other GTPases, their biological activities are 
controlled by a repeated GDP/GTP cycle, which is controlled by GEFs (RasGEF, 
SOS and CDC25) and GAPs (p120GAP, GAP1m, and NF1). Additionally, there is 
 19
 20
another regulator that is unrelated to GEF, GAP and GDI described above, called 
small G protein GDP-dissociation stimulator (GDS). GDS has two effects on small 
GTPases including Ki-Ras and Rho/Rac/CDC42/Rap1 proteins. It can stimulate 
GDP/GTP exchange reactions and inhibit their binding to membranes (Takai et al., 
2001). Newly synthesized Ras proteins are first associated with the ER and then with 
the Golgi apparatus, requiring only the C-terminal CAAX sequence and farnesylation. 
Further processings, including carboxylmethylation and AAX proteolysis, are 
necessary for proper association with the plasma membrane. 
Verified Ras effectors are characterized by a Ras-binding domain, which 
contains about 100 amino acids (Takai et al., 2001). There are at least three Ras-
binding domains that have been identified: the Ras-binding domain (RBD) of Raf or 
Tiam1; the RBDs in class I phosphoinositide 3-kinases (PI3K-RBDs); and the Ras 
association domains (RA), identified initially as a sequence homology found in 
RalGDS and AF-6 (Ponting and Benjamin, 1996; Takai et al., 2001; Repasky et al., 
2004). Raf, PI3K and RalGDS are the best characterized effectors and crystal 
structures of these effectors or Ras-binding domains complexed with Ras proteins 
have been solved (Nassar et al., 1995; Huang et al., 1998; Pacold et al., 2000; 
Scheffzek et al., 2001). The structures showed that all the Ras-binding domains 
shared the same topology, the ubiquitin fold (ββαββαβ)(Herrmann, 2003). Moreover, 
there are similar intermolecular interactions between these effectors and the Ras 
proteins. A β-strand in the Ras (interswitch β2) and a β-strand from the Ras-binding 
domains are aligned to form an extended antiparallel intermolecular β-sheet 
connecting Ras proteins and their effectors (Figure 1-6) (Herrmann, 2003; Repasky et 
al., 2004). 
Ral GTPases are part of extracellular signaling pathways and involved in the  
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regulation of a diverse array of cellular processes, including endocytosis, exocytosis 
and actincytoskeleton dynamics, via their interactions with various downstream 
effectors (Feig, 2003). Ral GTPase is localized to the plasma membrane, as well as to 
transport vesicles, suggesting that it is involved in membrane traffcking. It has been 
suggested that the Ral-Sec6/8 interaction is involved in the assembly of the tethering 
complex (Sec6/8 complex) and in the regulation of the basal-lateral distribution of 
proteins (Moskalenko et al., 2002; Fukai et al., 2003). Both exo84 and Sec5, two 
subunits of Sec6/8 complex, are effectors of Ral GTPases. The crystal structures of 
their Ral binding domains complexed with the Rala GTPase have been determined 
(Fukai et al., 2003; Jin et al., 2005). The structure of Sec5RBD is an Ig-like β-
sandwi  ch fold unlike the ubiquitin fold. However, the way it interacts with Rala is
similar to that of Ras-RDB described above. The intermolecular antiparallel β-sheet is 
formed by β1 from Sec5 and β2 from Rala (Fukai et al., 2003). The structure of Ras-
binding domain of exo84, which is also different from the previous RBDs, is a 
pleckstrin homology (PH) domain(Jin et al., 2005).  Surprisingly, RBD of exo84 also 
uses one β-strand to contact with β2 in the interswitch region of RalA, thus forming 
an extended parallel but not antiparallel β-sheet (Hanzal-Bayer et al., 2002; Jin et al., 
2005) (Figure 1-6). This strongly suggests that the effectors of Ras protein use a 
similar interaction mode to interact with Ras proteins by forming the extended parallel 
or antiparallel intermolecular β-sheet. 
In the complex structures, most of Ras proteins use their switch I and 
interswitch regions to contact their effector domains except for Raf and PI3Kγ. In the 
Rap-RafRBD complex, the switch II region of Rap also contacts RafRBD (Nassar et 
al., 1995). The switch II region of Ras interacts with the catalytic domain but not Ras-






Figure 1-6. Structures of the Ras protein-effector complexes. 
Rap-RafRBD (1C1Y) (Nassar et al., 1995), Ras-Byr2RBD (1K8R) (Scheffzek et al., 
2001), Ras-RalGDSRBD (1LFD) (Huang et al., 1998), Ras-PI3Kγ (1HE8) (Pacold et 
al., 2000), Rala-exo84RBD (1ZC3) (Jin et al., 2005) and Rala-Sec5RBD (1UAD)  
(Fukai et al., 2003). Switch I and switch II are shown in cyan and red, respectively. 
Nucleotide molecules are shown as stick models and Mg2+ as a cyan sphere. The Ras-
binding domain of PI3Kγ is shown in dark green while other domains of PI3Kγ are 
shown in orange. 
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switch I region contributes more to the specific binding of Ras proteins to their 
effectors than the switch II region. 
 
 
1.3.5.2 Rho family 
 The mammalian Ras homologous (Rho) proteins consisting mainly of Rho, 
Rac and CDC42 subfamilies serve as key regulators of extracellular-stimulus-
mediated signaling networks that regulate actin organization.  They play crucial roles 
in cellular functions such as cell shape change, cell motility, cell adhesion and 
cytokinesis. Like Ras proteins, Rho proteins are involved in gene expression mediated 
by signal transduction. Rac and CDC42 can activate the JUN N-terminal kinase (JNK) 
and p38 MAP kinase cascades, thus controlling gene transcription in response to 
extracellular stress such as UV light. In addition, Rho, Rac, and CDC42 have been 
suggested to activate serum response factor (SRF)-dependent transcription and the 
transcription factor NFκB (Mackay and Hall, 1998; Takai et al., 2001). Rho proteins 
are also involved in the membrane-trafficking processes of phagocytosis, endocytosis 
and secretory vesicle transport by the regulation of cytoskeleton reorganization (Takai 
et al., 2001). The activation and inactivation of Rho proteins are regulated by the 
me mechanism as Ras proteins by GEFs and GAPs, respectively. RhoGDI is 
roteins and keeping 
mammalian Rho proteins have been 
identified. The p160ROCKI, PKN and p140mDia proteins are well established 
sa
another regulator, binding to GDP-bound inactive form of Rho p
them in the cytosol.  The majority of Rho proteins are subject to the same CAAX-
signaled prenylation and post-translational modifications as those seen in the  Ras 
family (Takai et al., 2001; Colicelli, 2004). 
 Numerous downstream effectors of 
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effectors of the Rho subfamily. PAKs (p21-associated protein kinases) have a 
common CRIB (CDC42/Rac interactive binding) motif, and have been shown to be 
ommon effectors for Rac/CDC42. Another well-studied effector of CDC42 is called 
iskott-Aldrich syndrome protein (WASP). p67phox, a subunit of NADPH oxidase, 
ctor of Arf1 and Arf6, were shown to interact with Rac and their 
 
oA-PKN-RBD, RhoA-ROCKI-RBD and 
c
W
and arfaptin, an effe
complex structures have been determined (Lapouge et al., 2000; Rose et al., 2005). 
 The structures of Rho-GDP and Rho-GTP are shown in Figure 1-7. 
Compared with the structures of Ras, the unique feature of Rho proteins is that it 
contains a ~13-amino-acid insertion between β5 and α4 corresponding to Ras 
structure (Figure 1-7). The two small helical insertions in Rac/CDC42 are involved in 
the interaction with the downstream effectors. The structures of GDP-bound and 
GTP-bound forms of Rho are similar to Ras except for the insertion (Wei et al., 1997; 
Ihara et al., 1998). 
Solution structures of the CRIB motifs complexed with CDC42 have been 
determined (Abdul-Manan et al., 1999; Mott et al., 1999; Morreale et al., 2000) 
(Figure 1-8). Similar to the Ras-effector interaction, the core β-strand from CRIB 
motif and β2 in the interswitch region of CDC42 form the extended antiparallel 
intermolecular β-sheet. This suggests that some small GTPases in different families 
share the same interaction mode to interact with their effectors by forming the 
intermolecular β-sheet. The switch regions (switch I and switch II regions) and C-
terminal helix as well as β2 from CDC42 are also involved in the interaction with the 
CRIB motif (Figure 1-8).  
 An analysis of the interactions in Rh
Rac1-arfaptin shows different interactions between Rho proteins and their effectors by 







Figure 1-7. Structures of small GTPases. 
Ras-GDP (4Q21) (Milburn
RhoA-GDP (1FTN) (Wei et al.
 et al., 1990), Ras-GDPNP (5P21) (Pai et al., 1990), 
, 1997), RhoA-GTP (1A2B) (Ihara et al., 1998), Ran-
2+
GDP (1BYU) (Stewart et al., 1998), and Ran-GDPNP (1RRP) (Vetter et al., 1999c) 
Switch I and switch II are shown as cyan and red, respectively. Nucleotide molecules 
are shown in stick models and Mg  as a cyan sphere. 
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Figure 1-8. Structures of the Rho protein-effector complexes. 
CDC42-WASP-CRIB (1CEE) (Abdul-Manan et al., 1999), RhoA-PKN-RBD (1CXZ) 
(Maesaki et al., 1999), RhoA-ROCKI-RBD (1S1C) (Dvorsky et al., 2004), Rac1-
arfaptin (1I4T) (Tarricone et al., 2001), Rac-p67phox (1E96) (Lapouge et al., 2000), 
RhoC-mDiaN (1Z2C) (Rose et al., 2005). Switch I and switch II are shown in cyan 
and red, respectively. Nucleotide molecules are shown as stick models and Mg2+ as a 




(Maesaki et al., 1999; Tarricone et al., 2001; Dvorsky et al., 2004) (Figure 1-8).   The 
PKN Rho-binding domain forms an antiparallel coiled-coil (ACC) finger. The ACC 
finger interacts with the switch I and interswitch (β2 and β3) regions. Moreover, the 
C-terminal helix, corresponding to helix α5 in Ras, is involved in the interaction with 
the PKN Rho-binding domain (Maesaki et al., 1999) (Figure 1-8). The structure of 
the Rho-binding domain of ROCKI is a parallel α-helical coiled-coil homodimer. The 
switch I region of RhoA interacts with a helix in the parallel coiled-coil region from 
one protomer while the switch II region contacts another helix form the  other 
protomer (Dvorsky et al., 2004) (Figure 1-8). The structure of arfaptin is also a 
homodimer. Three α helices from one protomer and three α helices from the other 
protomer form an extended antiparallel six-helix bundle. The switch I and II regions 
of Rac1 interact mainly with the antiparallel helices from one promoter. Another helix 
from the other protomer also contributes to the interaction mainly with the switch I 
region (Tarricone et al., 2001).  
The interaction in Rac-p67phox and RhoC-mDiaN is not a typical interaction 
(Lapouge et al., 2000; Rose et al., 2005) (Figure 1-8). The switch and interswitch 
regions interact with the effector interface mainly formed by helices and loops. 
  
 
1.3.5.3 Ran family 
The Ra s-like nuclear (Ran) proteins are the most abundant small GTPases in 
cells and are involved in nucleocytoplasmic transport of RNA and proteins (Weis, 
2003). There is only one human Ran protein. Its activation and inactivation are 
regulated by a Ran-specific nuclear GEF and cytoplasmic GAP. In mammals, there is 
only one Ran GEF, regulator of chromosome condensation (RCC1), and one Ran 
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GAP, RanGAP1. The cargo nucleocytoplasmic transport requires transport receptor 
molecules, adaptor molecules, Ran and its binding proteins. Transport receptors 
constitute a superfamily of proteins that contain a binding domain for Ran-GTP. 
There are two types of transport receptors. Nuclear import receptors, called importins, 
recognize the nuclear location signal (NLS) of cargo molecules while nuclear export 
receptors, called exportins, recognize the nuclear export signal (NES) of cargo 
molecules. In some cases, transport receptors bind cargo molecules indirectly via 
adaptors that recognize NLS or NES. Two Ran-binding proteins (RanBPs) have been 
identified. RanBP1 is localized to the cytoplasm and can enhance RanGAP1 activity. 
RanBP2 is a component of nuclear pore complexes (NPCs) at the cytoplasmic face 
and also  enhances RanGAP1 activity (Takai et al., 2001).  
 In the nucleus, exportin binds Ran-GTP and its cargo molecules in a 
cooperative manner and the cargo molecules are transported to the cytoplasm through 
NPCs.  In the cytoplasm, Ran-GTP is bound by RanGAP1 and RanBPs, causing the 
convers
 keeps 
P-bound form. Then p10/NTF2 transports Ran-GDP back to the 
ucleus for the next cycle of transport (Takai et al., 2001).  
 another role in nuclear import. In the cytoplasm, importin-β 
ion of Rab-GTP to Ran-GDP. The conformational change caused by the GTP 
hydrolysis leads to the dissociation of cargo molecules into the cytoplasm. Ran-GDP 
forms a complex with another regulator, p10/NTF2, which has GDI activity and
Ran in the GD
n
Ran also has
forms a complex with importin-α which serves as an adaptor for binding to NLS-
containing cargo molecules. The cargo molecules are transported into the nucleus 
through NPCs. Ran-GTP in the nucleus binds to importin-β, causing the dissociation 
of the complex and the release of the cargo molecules (Takai et al., 2001). 
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The Ran structures showed that Ran proteins are a variation of Ras-related 
proteins, which have a long C-terminal extension ending in the conserved acidic 
DEDDDL motif (Figure 1-7). The C-terminal helix followed by DEDDDL motif is 
linked by the unstructural linker, which also contributes to the stabilization of the 
GDP-bound conformation. Similar to Arf proteins describe below, there is an extra β-
strand (β2E) in the structure of GDP-bound Ran (Stewart et al., 1998; Hanzal-Bayer et 
al., 2002) (Figure 1-7). The GTP-bound conformation has been determined indirectly 
by solving the Ran-effector complex. In the GTP-bound conformation, β2E disappears 
and adopts a conformation quite similar to that of Ras. There is also a large and 
striking conformational change in the C-terminal extension, which contributes to the 
interaction with the effector as described below (Ran-RanBD1) (Vetter et al., 1999b) 
aryopherin-β superfamily 
and stru
ook et al., 
1999; Vetter et al., 1999a; Matsuura et al., 2004; Lee et al., 2005). This indicates that 
(Figure 1-7). This suggests that the C-terminal switch is rather unfavourable and the 
unstable conformation of the GTP-bound Ran is stabilized by the effector-binding to 
the C-terminal extension. 
The structures of importin-β, Kap95p (yeast importin-β), karyopherin-β2 and 
Cse1p (Chromosome Segregation Protein 1, an exportin) complexed with Ran-GTP 
(or a GTP analogue) have implicated the functions of Ran in the nuclear import and 
export (Chook and Blobel, 1999; Vetter et al., 1999a; Matsuura and Stewart, 2004; 
Lee et al., 2005) (Figure 1-9). These carriers belong to the k
ctural studies have shown that these carriers bind Ran in a quite similar way. 
The structures of importin-β, Kap95p, karyopherin-β2 and Cse1p are consisted of 
HEAT repeats, which “clamp” around Ran. The HEAT repeats contact the switch and 
interswitch regions of Ran. Moreover, the basic patch around helix α5 and helix α6 in 




ction with RanBD1. Interestingly, Ran also uses the C-
termina
o-site (switch/interswitch regions and the basic patch) Ran-GTP clamping 
mechanism may be a general mode used by the karyopherin-β family to interact with 
Ran-GTP.  
 The structure of the Ran-GDP-NTF2 complex has been determined (Stewart et 
al., 1998) (Figure 1-9).  NTF2 consists of a distinctly bent β-sheet with one long α-
helix. Ran only uses the switch regions to contact NTF2. The hydrophobic residues in 
the upper portion of the NTF2 cavity and the negatively-charged residues surrounding 
the cavity make the major contribution to the interface with Ran-GDP. 
 The structure of the Ran-binding domain of RanBP2 complexed with Ran-
GTP analogue (Ran-RanBD1) has implications for nuclear transport (Vetter et al., 
1999c). RanBD1 has a PH domain fold like exo84RBD (Figure 1-6). However, the 
interface between Ran and RanBD1 is more complicated and different from that of 
Rala-exo84RBD. Only the switch I and interswitch regions (not the switch II region) 
are involved in the intera
l switch to contact with RanBD1. The C terminus of Ran-GTP is wrapped 
around RanBD1, contacting a basic patch on the surface of the RanBD1 core (Vetter 
et al., 1999c) through its acidic end.  The N-terminal segment of RanBD1 extends to 
contact with β2 and β3 of Ran (Figure 1-9). This mechanism by which Ran utilizes 
the unique C-terminal switch as well as typical switch regions represents a new type 







Figure 1-9. Structures of the Ran-carrier and Ran-effector complexes. 
Ran-Cse1p (1WA5) (Matsuura et al., 2004), Ran-importin-βN (1IBR) (Vetter et al., 
1999a), Ran-Kap95p (1BKU) (Lee et al., 2005), Ran-karyopherin-β2 (1QBK) 
(Chook et al., 1999), Ran-NTF2 (1A2K) (Stewart et al., 1998), and Ran-RanBD1 
(1RRP) (Vetter et al., 1999c). Switch I and switch II are shown in cyan and red, 




1.3.5.4 Arf and Rab family  
 The functions of Arf and Rab proteins will be described in the following 
sections. The aim of these two projects is to focus on these two small GTPase families, 
Rab and Arf, and their effectors. Therefore, the following sections will focus on these 
two families and their specific effectors, called Golgins containing GRIP domain and 
RILP (Rab-interaction lysosomal protein), respectively.  
 
 
1.4 Arf, Ar1 and GRIP domain 
1.4.1 Arf family 
The small GTPases of the ADP-ribosylation factor (Arf) family are classified 
into the Sar, Arf and Arl (Arf-like) subfamilies. There is only one SAR1 gene in yeast. 
Two Sar1 proteins (Sar1a and Sar1b) have been found in mammals. The SAR1 gene 
was originally isolated as a multiple copy suppressor of a ts mutant of the SEC12 gene 
(Sar1 GEP gene) that had been genetically identified to be required for the transport 
from the ER to the Golgi apparatus in the yeast S. cerevisiae. Subsequently, the SAR1 
gene was also shown to be involved in the transport from the ER. It is localized at the 
ER exit sites and intermediate compartment (IC). Active Sar1 is believed to recruit the 
COPII coat for subsequent vesicle budding from the ER exit sites or IC complex 
(Randazzo et al., 2000; Takai et al., 2001).  
  Arfs were originally identified as cofactors required for cholera toxin-
 
 
catalysed ADP-ribosylation of the stimulatory component of adenylate cyclase Gs
(Kahn and Gilman, 1984) and have been shown to be important for membrane 
trafficking at several stages of the exocytic and endocytic pathways (Balch et al., 
1992; Kahn et al., 1992; Zhang et al., 1994; Peters et al., 1995). The prototype of the 
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Arf family, Arf1, was purified and cloned from bovine (Kahn et al., 1984; Kahn and 
ilman
i et al., 2001). All Arfs can 
rve as cofactors to stimulate the ADP-ribosylation of Gαs by cholera toxin, rescue 
e lethal phenotype of arf1-/arf2- yeast and activate phospholipase D (PLD). There 
ily and they have more than 60% identity to each 
 been classified into three classes. Class I members consisting of 
Arf1, 2
, 1994; Boman and Kahn, 1995; Lowe et 
 19
G , 1986; Sewell and Kahn, 1988). Other mammalian Arfs were subsequently 
isolated by low stringency hybridization screening (Bobak et al., 1989; Tsuchiya et al., 
1991), and anchorage-independent cellular phenotype screening (Kahn et al., 1991). 
  The classification of Arf subfamilies is based on the following three activities 
possessed by all Arfs (Moss and Vaughan, 1998; Taka
se
th
are six members of the Arf subfam
other. They have
, and 3 are mainly associated with the Golgi apparatus and endosomes and 
regulate vesicle budding for several transport events. Class II consists of Arf4 and 5, 
whose locations and functions are less well defined. Arf6 is the only member of class 
III and has been shown to coordinate actin cytoskeleton with membrane traffic and 
cell motility (Turner and Brown, 2001). 
   In additional to Sar and Arfs, there are a number of other Arf-like proteins, 
referred to as Arls, which are homologous to Arfs but do not show the above 
mentioned Arf activities. There are 17 Arls in humans, some of which are widely 
conserved in evolution (Burd et al., 2004; Li et al., 2004). Arls are ~40–60% identical 
to each other and to Arfs (Schurmann et al.
al., 96; Ingley et al., 1999; Jacobs et al., 1999). Although Arls are highly 
homologous to Arfs, Arls have diverse functions and localizations. Only Arl1 and 
Arf-related protein 1 (ARFRP1) are localized to the TGN, where they function to 
regulate the tethering of endosome-derived transport vesicles. Other Arls are 
distributed in the cytosol, mitochondria, and/or nucleus (Schurmann et al., 1994; 
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Boman et al., 1995; Lowe et al., 1996; Ingley et al., 1999; Jacobs et al., 1999; Sharer 
et al., 2002; Burd et al., 2004). Their biological and physiological functions remain to 
be further established.  
The classification of Arls is still under debate (Pasqualato et al., 2002; Burd et 
al., 200
0). Additionally, the conserved aspartate (D) 
4). To date, the structures of GDP- or GTP-bound forms of Arf1, Arf2, Arf6, 
Arl1, Arl2, Arl3, and Sar1 have been solved (Nakano and Muramatsu, 1989; Amor et 
al., 1994; Menetrey et al., 2000; Hillig et al., 2000; Amor et al., 2001; Pasqualato et 
al., 2001; Huang et al., 2001; Hanzal-Bayer et al., 2002). On the basis of these solved 
structures, it was suggested that the classification of the Arf family described above 
by their amphipathic helical N-termini and interswitch toggles, which are the β2-β3 
strands connecting the switch I and switch II regions (Pasqualato et al., 2002). Briefly, 
in the GDP-bound conformations of Arfs, the interswitch region is retracted, forming 
a pocket for N-terminal amphipathic helix, which serves as a molecular hasp to 
maintain Arf proteins in the inactive conformation (Amor et al., 1994; Greasley et al., 
1995; Menetrey et al., 2000) (Figure 1-1
in the G3 box (DxxG) mimics the charge of the γ-phosphate of GTP, thus contributing 
to the prevention of GTP binding. In the GTP-bound conformation, the interswitch 
region undergoes a 2-residue register shift, thus pulling the switch I and switch II 
regions “up”. The interswich region projects out of the proteins and extrudes the N-
terminal hasp by occupying its binding pocket (Figure 1-10) (Goldberg, 1998; 
Pasqualato et al., 2001).  
Except for Arl4, Arl6, Arl7 and ARD1, all members of the Arf family, 
including ARFRP1, have the interswitch toggles, which confer the ability of “front-
back communication” (Pasqualato et al., 2002). The presence of this communication 
mode might provide a more useful basis for reunifying Arf homologs as a family than 
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test the cellular functions of these proteins, which are mostly unrelated. On the basis 
of the structural comparisons and sequence analysis, it was proposed that Arl4, Arl6 
and Arl7 comprise a non-interswitch toggle group, undergoing the classical GDP/GTP 
structur
                       
al cycle of other small GTPases such as Ras. Due to the absence of interswitch 
toggles of this group of small GTPases, it was predicted that the formation of a pocket 
harboring the N-terminal amphipathic helix and the docking of which inhibits the 
guanine nucleotide exchange of small GTPases, would not occur. Biochemical 
analysis supported this point by the finding that Arl4, Arl6 and Arl7 have fast intrinsic 
guanine nucleotide exchange activity (Jacobs et al., 1999). The structural interswitch 
toggles might be used as a determinant of most subfamilies. Based on this determinant, 
the Arl8 is a novel subfamily of Arf GTPases. This finding can be examined by 
sequence and functional data (Pasqualato et al., 2002). 
 
 
Figure 1-10. The interswitch toggle of human Arf6. Arf6-GDP (Menetrey et al., 
orientation. Residues with disordered electron density are indicated by a dashed line 
signature sequences are shown (Adapted from Pasqualato et al., 2002). 
2000) (left) and Arf6-GTP (Pasqualato et al., 2001) (right) are shown in the same 
and are expected to interact with membranes in activated Arf. Invariant residues of the 
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1.4.2 Arl1 and GRIP domain 
   Arl1 was originally cloned from Drosophila and found to be essential for 
normal development (Tamkun et al., 1991). The mammalian Arl1 was subsequently 
identified (Schurmann et al., 1994; Zhang et al., 1995; Lowe et al., 1996), and the 
expression of Arl1 is ubiquitous among various tissues in animals (Lowe et al., 1996; 
Hong et al., 1998). Arl1p, the only yeast homologue of Arl1, was cloned by 
degenerate PCR and shown to be non-essential for yeast viability (Tamkun et al., 
1991; Lee et al., 1997). Arl1 is one of the most highly conserved Arls and a single 
homologue of Arl1 is present in the genome of most eukaryotes examined to date. 
Arl1 has all the typical features of Arf proteins including an amphipathic N-terminal 
helix and a consensus site for N-myristolyation at glycine of position 2 (Kahn et al., 
1988; Lee et al., 1997; Munro, 2005).  
Arl1 is one of the most studied members of the Arl subfamily. It is the only 
member of the Arl subfamily except for ARFRP1 which has been shown to be Golgi 
associated and function in the TGN, thereby regulating the structure and function of 
the Golgi apparatus (Lu et al., 2001; Van Valkenburgh et al., 2001). Like other small 
GTPases, the overall function of Arl1 is presumably to recruit specific effectors to the 
trans-Golgi. Proteins that specifically bind GTP-bound Arl1 have been identified by 
yeast two-hybrid screens and yeast genetics. The results showed that GTP-bound Arl1 
binds the GRIP domain, a conserved sequence of about 50 residues that is found at the 
C-terminus of a number of Golgi-localized large coiled-coil proteins (Figure 1-11) 
(Lu and Hong, 2003; Setty et al., 2003; Panic et al., 2003b). This conserved domain 
was first identified to locate at the extreme C-termini of Golgin-97, RanBP2α, Imh1p 
and p230/Golgin245, called the GRIP domain. The GRIP domain has been shown to 





Figure 1-11. Alignment of the amino acid sequences of GRIP domains. The 
human (prefix h) and Drosophila (prefix d) Golgins defines several conserved 
residues of the GRIP domains. The most conserved residues are indicated in red with 
a yellow background. The intermediate conserved residues are shown in blue under 
light blue background and the residues conserved in only some GRIP domains were 




mechanism (Munro and Nichols, 1999; Barr, 1999; Kjer-Nielsen et al., 1999a; Kjer-
Nielsen et al., 1999b; Brown et al., 2001; Luke et al., 2003). In mammals, there are 
four G
also 
RIP domain proteins, Golgin-245, Golgin-97, GCC88 and GCC185.  In 
addition to the C-terminal GRIP domain, all of these peripheral membrane proteins 
are large and contain coiled-coil structures that are indicative of dimeric rod-shaped 
structures. Such a coiled-coil structure is present in Golgins, a family of Golgi-
localized proteins with extensive coiled-coil regions, which have been proposed to 
serve as Golgi matrix and vesicle tethering molecules (Gillingham and Munro, 2003). 
These GRIP domain proteins function as vesicle tethers that promote transport-vesicle 
targeting by mediating long-range contacts between opposing membranes. This 
suggests that Arl1 may regulate vesicle trafficking by recruiting vesicle tethers 
(Whyte et al., 2002; Barr and Short, 2003; Burd et al., 2004; Graham, 2004). 
 Little is known about the GRIP domain except that some conserved residues 
such as the conserved aromatic residues are critical for the Golgi localization of the 
GRIP domain and interaction with Arl1. The Arl1-GRIP domain interaction is 
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dependent on the switch II region of GTP-bound Arl1 (Munro et al., 1999; Barr, 1999; 
Kjer-Nielsen et al., 1999a; Lu et al., 2003). The molecular details of the interaction 
between Arl1 and the GRIP domain remain elusive. 
 
 
1.5 Rab family, Rab7 and RILP 
1.5.1 Rab family 
First described as  Ras-like proteins in brain, Rab proteins, as the general 
regulators of intracellular vesicle transport between donor and acceptor membranes as 
described above, comprise the largest small GTPase subfamily with more than 60 
quently 
members in mammals, and share an average sequence identity of ~30% (Pereira-Leal 
and Seabra, 2000; Takai et al., 2001; Pereira-Leal and Seabra, 2001).  Most Rab 
proteins regulate the targeting, docking and fusion processes and some of them 
regulate the budding process, which is mainly regulated by Sar1/Arf proteins (Takai 
et al., 2001). Rab proteins are intrinsically cytosolic proteins and behave as 
membrane-associated molecular switches to regulate vesicle transport (Zerial et al., 
2001; Pfeffer, 2001). In common with other GTPases of the Ras superfamily, Rab 
proteins cycle between active (GTP-bound) and inactive (GDP-bound) conformations, 
regulated by GEFs, GAPs and GDIs. In the cytosol, a Rab protein is bound by a GDI 
to maintain it in a GDP-bound inactive form. The GDP-bound form is first released 
from the GDI by a still unknown mechanism that is coupled to the delivery of the Rab 
protein to a specific membrane compartment. The Rab protein is subse
converted to a GTP-bound form by a GEF. This active form can recruit diverse 
effectors and be associated with the membrane. Thereafter, the GTP-bound form is 
converted to the GDP-bound form by the action of the GAP and releases its effectors. 
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The GDP-bound form is still associated with the membrane. Then it is complexed 
with the GDI and returns to the cytosol as a Rab-RabGDI complex (Takai et al., 
2001). Isoprenylation at the C-terminus is a prerequisite for membrane attachment to 
tracellular organelles and vesicles (Calero et al., 2003). The newly synthesized 
DP-bound Rab proteins are bound by REP (Rab escort protein) and delivered to Rab 
enylation. After prenylation, REP delivers Rab 
in the vesicular traffic (Alory et al., 2001).  
in
G
geranylgeranyl transferase for pr
proteins to the membrane for use 
   Sequence analysis of Rab proteins showed that they share some specific and 
conserved Rab family motifs (RabF1 to RabF5) clustered in and around the switch I 
and switch II regions (Pereira-Leal et al., 2000). These motifs, combined with the 
conserved PM/G motif and double-cysteine C-terminal prenylation, allow the 
definition of a Rab protein. In addition, the Rab subfamily has some specific motifs, 
called RabSF motifs (RabSF1 to RabSF4). These motifs are unique characteristics for 
Rab subfamily, suggesting that Rab proteins may use the switch regions and these 
RabSF motifs to interact with their effectors or regulators (Pereira-Leal et al., 2000). 
   It has become clear that Rab proteins are multifunctional and have multiple 
effectors often unrelated to each other (Zerial et al., 2001; Pfeffer, 2001). A key 
question concerns the molecular mechanism by which Rab proteins generate 
specificity for a diverse spectrum of effectors and regulatory factors.  Biochemical 
and genetic studies on chimeric and mutant Rab proteins have identified several 
hypervariable regions that play an important role in determining functional specificity 
(Brennwald and Novick, 1993; Stenmark et al., 1994). Consistent with these findings, 
the crystal structure of the Rab3a-Rabphilin3a (Ostermeier and Brunger, 1999) 
complex revealed that both switch regions and three hypervariable regions, referred to 
as Rab complementarity-determining regions (RabCDRs) or RabSF motifs (RabSF1, 
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RabSF3, RabSF4), are involved in the Rab3a-Rabphilin3a interface. These 
observations led to the hypothesis that independent RabSFs may determine the 
specificity of Rab-effector interactions.  
This was the only crystal structure reported before this work was initiated. 
This project focused on another well-studied Rab GTPase, Rab7 and its effector, 
Rab7-interacting lysosomal protein (RILP). The initial aim was to provide more 
information about the mechanism of Rab-effector interactions by determining the 
. 
crystal structure of the Rab7-RILP complex.  
 
 
1.5.2  Rab7 and RILP 
   Rab7 is localized on the late endosome and the lysosome. A constitutively 
active mutant of Rab7 can regulate vesicle traffic from the late endosome to the 
lysosome while the dominant negative mutant can inhibit the vesicle traffic from the 
early to late endosome (Feng et al., 1995; Meresse et al., 1995; Press et al., 1998)
Furthermore, Rab7 is involved in lysosome biogenesis, controlling aggregation and 
fusion of late endocytic structures/lysosomes and is essential for maintenance of the 
perinuclear lysosome compartment (Bucci et al., 2000). Recent studies suggest that 
Rab7 has new functions besides the regulation of the vesicle traffic from the early 
endosome to the late endosome or from the late endosome to the lysosome.  Rab7 
may function as a proapoptotic protein by limiting cell autonomous nutrient uptake. 
Blocking Rab7 function prevents the clearance of the glucose and amino acid 
transporter protein from the cell surface (Edinger et al., 2003). Another new function 
for Rab7 is that it can play a role in the autophagic pathway. The Rab7 dominant 
negative mutant was shown to be targeted to the autophagosome vesicles by a signal 
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transduction mechanism induced by amino acid deprivation (Gutierrez et al., 2004). 
More recent studies showed that Rab7 is also involved in monocytic differentiation of 
human acute promyelocytic leukemia cells (Yang et al., 2004). However, the exact 
mechan
two-hybrid screen to be localized to the 
te endosomal and lysosomal membrane (Cantalupo et al., 2001). It is a novel 45 
Da protein and contains two coiled-coil regions typical of myosin-like proteins and 
ytosol (Cantalupo et al., 2001). RILP is mainly cytosolic and 
ism of action of Rab7 in the vesicle trafficking is still not known. Therefore, it 
is important to isolate and characterize Rab7-interacting components. 
 Two Rab7 effectors, RILP (Rab7-interacting lysosomal protein) and Rabring7, 
a novel RING finger protein, have been characterized (Cantalupo et al., 2001; Mizuno 
et al., 2003). RILP was identified by a yeast 
la
k
is mainly found in the c
can be recruited to the late endosomal and lysosomal membranes by Rab7. RILP 
represents a downstream effector for Rab7 and both proteins act together to regulate 
the late endocytic traffic. Domain search and recent studies suggest that RILP may be 
involved in the Rab7-dependent late endocytic traffic associated with motor 
complexes (Cantalupo et al., 2001; Harrison et al., 2003; Marsman et al., 2004). 
Recruitment of RILP by Rab7 is important for phagosome maturation and essential 
for their fusion with later endosomes and lysosomes associated with the microtubule 
motor complex, thus preventing the maturation of invasion vacuoles of Salmonella 
and inhibits Salmonella replication (Harrison et al., 2003; Harrison et al., 2004). 
Two novel proteins related to RILP have been identified and are tentatively 
referred to as RLP1 and RLP2 (for RILP-like protein 1 and 2, respectively). A 
sequence alignment shows that RILP contains a region not present in RLP1 and RLP2 
(Figure 1-12). Studies on chimeric proteins between RILP and RLPs showed that a 
62-residue unique region (residues 272-333) in RILP is responsible for its specific 
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role in regulating lysosomal morphology as well as interacting with Rab7-GTP (Wang 
et al., 2004). However, the molecular mechanism which Rab7 utilizes to interact with 
RILP and recruit it to late endosomes and lysosomes remains elusive. 
As described above, a model in which RabSF1, RabSF3 and RabSF4 are 
involved in the Rab3a-Rabphilin3a interaction has been used as  a general model to 
account for other Rab-effector interactions for several years (Ostermeier et al., 1999). 
However, a recent structural study on the Rab5-Rabaptin5 complex challenged this 
rule  by showing that only the switch regions are involved in the Rab5-Rabaptin5 
interactions(Zhu et al., 2004). This observation suggests that Rab proteins utilize 





Figure 1-12.   Identification of two novel proteins (RLP1 and RLP2) related to 
RILP. The amino acid sequences of human (h) and mouse (m) RILP, RLP1 and 
RLP2 were aligned. The residues identical or conserved in all proteins were shown in 
red with a yellow background. Residues identical or conserved in five proteins were
shown in blue with a light blue background, while residues identical or conserved
 
 in 4 
protein
2004). 







1.6 The aims of the Projects  
1.6.1  Arl1-GRIP domain project  
 Previous studies have shown that conserved critical residues are important for 
GRIP domain localization. The switch II region of Arl1 confers the specificity of the 
interaction with the GRIP domain (Lu et al., 2003). However, the mechanism by 
which the GRIP domain is recruited by Arl1-GTP is unknown.   To understand how 
Arl1 recruits Golgins containing GRIP domain to the Golgi apparatus, the structure of 
the Arl1-GRIP domain complex will be determined by X-ray crystallography. The 
structural information will be used for the subsequent mutagenesis studies to further 
investigate the functions of Arl1 and GRIP domain in vivo.  
 
 
1.6.2 Rab7-RILP effector domain project 
   At the commencement of this project, the structural data are only available for 
the Rab3a-Rabphilin3a complex. The structure of this complex showed that RabSF 
motifs as well as switch regions were involved in the Rab-effector interaction 
(Ostermeier et al., 1999). The main aim of this project is to investigate the molecular
 interacting with RILP will be compared with other Rabs in complex with 
eir effectors.   
 
mechanism by which RILP is recruited by Rab7.  Structural information gathered will 
be used for site-directed mutagenesis to furher elucidate the functional roles of RILP 





                                  
apter 2   
 
2.1 Materials 
   2.1.1 Bacteria 
   DH5α                                                            Invitrogen 
   BL21 STAR (DE3) pLysS                           Invitrogen 
 
2.1.2 Culture media 
     LB (Luria Bertani) medium                      1% (w/v) peptone, 0.5% (w/v) yeast   
extract, 1% NaCl, pH 7.4  
1.5% agar in LB medium 
 
 Human Golgin-245 GRIP domain (residues 2171-2230) 
     5’:  CGCGGATCC
                                        Ch
                            Materials and Methods  
     LB agar medium                                        
 
2.1.3 Vector 
  pGEX-6p-1                                                Amersham Biosciences 
 
2.1.4 Constructs 
  All original constructs including human Golgin-245 GRIP domain, rat Arl1, 




     3’:  ACGCGTCGACTCAGAAGATACCACTGCGAGG 
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Rat N-terminus truncated Arl1 (residues 14-181) 
    5’:  CGCGGATCCAGGGAAATGAGGATTTTAATTTTG 
    3’: ACGCGTCGACTCACTGTCTGCTTTTCAGTGT 
Human full-length Rab7 
ATCC
 
   5’: CGCGG ATGACGTCTAGGAAGAAAGTGTTG 
AG   3’: CCGCTCG TTAGCAACTGCAGCTTTCTGCCGAG 
after as RILPe) Human truncated RILP (residues 241-320; denoted here
   5’:  CCGGAATTC TGCCGCTTCAGTCGGGA 
   3’:  CGCGTCGACTTAGCCAGCCTCATCCTCACT 
  Sal I                                                           New England Biolabs 
                                            New England Biolabs 
dNTP                                                        New England Biolabs 
                                   New England Biolabs 
 
    Alkaline Phosphatase                               Roche Diagnostics 
 
ease                                Amersham Biosciences 
 
2.1.6 Enzymes and nucleotides 
  BamH I                                                      New England Biolabs 
  EcoR I            
  XhoI                                                          New England Biolabs 
  
  T4 DNA ligase      
  Taq DNA polymerase                              New England Biolabs 
  Pfu DNA polymerase                               Stratagene 
  PreScission Prot
 
2.1.7 Kits 
  QIAquick  PCR purification kit                QIAGEN 
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  QIAprep Spin Miniprep kit                       QIAGEN 
Crystallization kits                                     Hampton Research 




 2.2 Molecular cloning 
 2.2.1 Polymerase chain reaction (PCR) 
  QIAquick Gel Extraction kit                     QIAGEN 
  Coomassie Protein Assay kit                     PIERCE 
  
   
2.1.8 Column Materials 
  Gluthione Sepharose 4B  
  HiPrep Desalting column 
  HiLoad Superdex-75 prep grade  




  Multiple Purpose Agarose                                       Roche Diagno
  30% Acrylamide/Bis solution (29:1)                       Bio-Rad 
  IPTG                                                                        Invitrogen 
  PEG-3350                                                                Hampton Res
  Other chemicals were purchased from Sigma-Aldrich 
 
2.1.10 Crystallization kits and tools 
    All crystallization kits and tools were purchased from H
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      High fidelity Pfu DNA polymerase was used to amplify the genes from 
μl PCR reactions contained the 
 3’ primer, 5 μl 10×Pfu buffer , 
 mM dNTP, 40.8 μl 
tilled H2O, 0.2 μl template (plasmid). The PCR reactions were done on an iCycler 
a ith the following cycling parameters:  
 seconds 
s 
    72˚C 2 minutes per 1 kb DNA fragment 
5˚C   ∞. 
 
fer. 
 PCR products were purified with a QIAquick PCR purification kit according 
.4 Enzyme digestion, dephosphorylation and purification 
me digestion of PCR products and vector was done with the 
ucts or pGEX-6p-1 vector, 1 μl restriction 
enzymes, 2 μl 10×BSA, 2 μl reaction buffer, 4 μl water. The digestion was incubated 
constructs from Prof. Hong Wanjin’s laboratory.  50 
following mixture : 1 μl 10 μM 5’ primer, 1 μl 10 μM
1 μl Pfu DNA polymerase, 0.5 μl 100 mM MgSO4, 0.5 μl 25
dis
Therm l Cycler (Bio-Rad) w
95˚C 2 minute 
30 cycles                95˚C 30
                               50˚C 30 second
                           
72˚C 15 minutes 
1
 
2.2.2 Agarose gel electrophoresis 
   5 μl PCR products were run on a 2% agarose gel mixed with 1×TAE buffer
(40 mM Tris, 1.14% acetic acid, 1 mM EDTA) as a running buf
 
2.2.3 Purification of PCR products 
  
to the manufacturer’s instructions. 
 
2.2
   Restriction enzy
following 20 μl mixture: 10 μl PCR prod
 47
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in 37 C for 3-4 hours. The vector mixture was treated with additional calf intestine 
alkaline phosphatase at 37˚C for 1 hour. The calf intestine alkaline phosphatase was 
inactivated at 75˚C for 10 minutes. The digested products were separated on an 
agarose gel as described above. The digested DNA fragments were cut from the gel 
and purified with a QIAquick Gel Extraction kit according to the manufacturer’s 
instructions. 
˚
 the following: 5 μl digested PCR products, 12 
ation was performed at 
 for about 4 hours. 5 μl ligation mixture was mixed with 100 μl 
petent cells and incubated on ice for 20 minutes. The competent cells 
ere heat shocked at 42˚C for 1 minute. 750 μl cold LB medium was added to the 
cubated at 37˚C for 45 minutes and spun down. 
id preparation 
itive clones were selected with PCR using Taq 
NA polymerase. 25 μl mixtures were made as follows: 2.5 μl polymerase buffer, 
 μM 3’ primer, 0.25 
 25 
 
2.2.5 Ligation and transformation 
   The ligation reaction contained




competent cells. Then they were in
The cells were plated on LB agar plates (1.5%) containing 100 μg/ml ampicillin. The 
plates were incubated at 37˚C overnight.  
 
2.2.6 Postive clone selection and plam
  Clones were picked and inoculated in 5 ml LB medium containing 100 μg/ml 
ampicillin at 37˚C overnight. Pos
D
0.5 μl Taq DNA polymerase, 0.5 μl 10 μM 5’ primer, 0.5 μl 10
μl mM dNTP, 19.75 μl water, 1 μl overnight-inoculated cells. PCR was done as 
described above except the extension time is 1 minute per 1kb DNA fragment. The 
PCR products were separated on a 2% agarose gel. The positive clones were selected 
 48
 49
for plasmid preparation. Plasmids were prepared using a QIAprep Spin Miniprep kit 
according to the manufacturer’s instructions.  
 
2.2.7 DNA sequencing 
   The sequences of those positive clones were confirmed by DNA sequencing. 
The PCR reaction was assembled as follows: 8 μl BigDye 3.1 sequencing mixture, 5 
l prepared plasmid, 1 μl 10 μM sequencing primer, 6 μl water. The sequencing 
 manufacturer’s protocol: 96˚C 1 minute, 25 
ompetent cells were used. The cells were 
lated on LB agar plates (1.5%) containing 100 μg/ml ampicillin and 34 μg/ml 
rnight. 
μ
reaction was done according to the
cycles (96˚C 10 seconds, 50˚C 5 seconds, 60˚C 4 minutes), ramp to 4˚C. The 
purification of PCR products and DNA sequencing were carried out in an ABI Prism 
377 DNA sequencer (Perkin Elmer) by staffs in the DNA sequencing unit of IMCB.  
 
2.2.8 BL21 Star transfomation  
   The plasmids with correct DNA sequences were selected for transformation 
into BL21 Star cells. The transformation was performed as described above except 
that 1 μl plasmid and 20 μl BL21 Star c
p
chloramphenicol. The plates were incubated at 37˚C ove
 
2.3 Testing expression of cloned genes 
   The clones were picked into 2 ml LB medium containing 100 μg/ml 
ampicillin and 34 μg/ml chloramphenicol and grown overnight at 37˚C. 100 μl cells 
were added into 10 ml fresh LB medium and shaken at 37˚C. When the optical 
density at 600nm (OD600) reached about 0.6, 0.5 mM IPTG (final concentration) was 
added to induce gene expression. The cultures were further shaken for 3 hour at 
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37˚C. The cells were spun down and lysed with SDS-PAGE loading buffer. The 








Brilliant Blue R-250), and then destained with 5% methanol and 7.5% acetic acid. 






 Large-scale cell culture 




  SDS polyacrylamide gel electrophoresis (SDS-PAGE) was performed 
ccording to the method of Laemmli (Laemmli, 1970). Discontinuous SDS-PAGE 
ith a stacking gel (pH 6.8, 0.125 M Tris-HCl, 0.1% SDS and 5% acrylamide/Bis 
olution) and resolving gel (pH 8.8, 0.375 M Tris-HCl, 0.1% SDS and 15% 
crylamide/bis solution) was conducted in 1 ×SDS running buffer (20 mM Tris Base, 
00 mM glycine, 0.1% SDS) at 25 mA. After SDS-PAGE, the gel was stained in 
oomassie staining buffer (45% methanol, 10% acetic acid and 0.25% Coomassie 
.5 Cell storage 
 The cells that expressed the fusion proteins were stored at -80˚C in about 40% 
lycerol (final concentration). 
2.6
   The cells were inoculated in 100
am illin and 34 μg/ml chloramphenicol at 37˚C overnight. 60 ml of cell culture 
was added into 6 liters LB medium and shaken at 37˚C. When the OD600 reached 
about 0.6, 0.2 mM IPTG (final concentration) was added to the medium. The cells 
were further shaken for 6 hours at 25˚C. The cells were harvested, washed with lysis 







e cells were streaked on the SD/-Trp/-Leu/-His/-Ade (QDO) plate. Occasionally, 
 SD/-Trp/-Leu medium, the diploid yeast cells were assayed by 







he following experiments (2.7-2.10) were done by Dr. LU Lei and Dr. WANG 
uanlao in Prof. Hong Wanjin’s laboratory. 
2.7 Site-directed mutagenesis 
 The site-directed mutations of all constructs were generated using standard 
PCR-mediated mutagenesis (Lu and Hong, 2003; Wang and Hong, 2002). 
 
2.8 Yeast two-hybrid assays 
Gal4-BD constructs in pGBKT7 and Gal4-AD constructs in pGADT7 (or in 
pACT2 vector for those positive clones from yeast two-hybrid screening) were 
transformed into AH109 and Y187 yeast cells respectively. Transformed AH109 and 
Y187 yeast cells were mated and the resulting diploid yeast cells expressing GAL4-
BD and GAL4-AD fusion constructs were selected on SD/-Trp/-Leu medium and then
th
after selection on
streaking them on QDO plates containing 20µg/ml X-α-gal (BD Clontech). The 
interaction positive diploid yea
 
2.9 Cell culture and transfec
 HeLa cells were grown in DMEM supplemented with 10% fetal bovine serum 
Gibco, Ann Arbor, MI) in a 5% CO2 incubator at 37°C. Transfection was performed 
sing Lipofectamine (Life Technologies, Gaithersburg, MD) or Effectene 
ransfection Reagent (QIAGEN) (Lu et al., 2001; Wang and Hong, 2002). 
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2.10    Indirect immunofluorescence microscopy 
2.10.1 Paraformaldehyde fixation 
   Cells on cover slips were washed with PBS containing 1 mM CaCl2 and 1 mM 
erature before fixation in 4% paraformaldehyde (4% 
by PBSCM 
t room temperature, and subsequently permeabilized by incubation with 0.1% 
r 20 min at room temperature. 
 
dies using 
ppropriate dilution in Fluorescence Dilution Buffer (PBSCM with 5% fetal bovine 
s  room temperature. Cells were then washed by 
PBSCM
ame, CA, 
SA) on microscopic glass slides. Confocal microscopy was performed by using a 
eiss Axioplan II microscope equipped with a Bio-Rad MRC1024 confocal scanning 
MgCl2 (PBSCM) at room temp
paraformaldehyde in PBSCM) for 15 min at room temperature. The cells were then 
washed twice by PBSCM, twice by 200 mM NH4Cl in PBSCM and twice 
a
Saponin (Sigma) in PBSCM fo
2.10.2    Methanol fixation 
   After washing by PBSCM, cover slips were immersed in methanol at – 20°C 
for 5 minutes and the system was then transferred to room temperature for another 5 
minutes. The fixed cells were washed extensively by PBSCM to remove trace the 
amount of methanol and then were ready for immunofluorescence labeling. 
 
2.10.3    Indirect immunofluorescence labeling 
   Fixed and permeabilized cells were incubated with primary antibo
a
erum and 2% BSA) for 1 hour at
 and incubated with FITC, Rhodamine or Texas-red conjugated secondary 
antibodies diluted (usually 100 times) in Fluorescence Dilution Buffer at room 
temperature for 1 hour. After extensive washing by PBSCM, the cells were then 





laser (Bio-Rad, Hercules, CA, USA). The images were displayed and analyzed using 
otoshop (Adobe) softwares.  
its mutants were cloned 
to pEGFP-C1 vector (BD clontech). The indicated RILP and Rab7 constructs were 
ls. The transfected cells were fixed and immuno-stained 
LaserSharp (Bio-Rad) and Adobe Ph
   For the Arl1-GRIP project, mutants of the GRIP domain were cloned into 
pEGFP-C2 and individually transfected into HeLa cells (Lu et al., 2001). After 
labeling of Golgi apparatus using GM130 monoclonal antibody (BD transduction 
Laboratories), cell localization was viewed as described above. 
   For the Rab7-RILP project, the wild type and mutated RILP were cloned into 
pDMYCneo vector (Wang et al., 2004). The Rab7Q67L and 
in
co-transfected into HeLa cel





2.11 Protein purification 
2.11.1 Cell lysis and Glutathione Sepharose affinity chromatograhy 
   The stored cells were thawed at room temperature, and resuspended in lysis 
buffer (20 mM Tris, 500 mM NaCl, 2 mM DTT, 2 mM benzamidine, 100 μM PMSF, 
1 mM EDTA, pH 8.0). Hen egg lysozyme was added to the resuspended solution at a 
final concentration of 1 mg/ml.  The resuspended solution was incubated on ice for 
30 minutes. The cells were subjected to sonication with 8 bursts of 15 seconds using 
a Soniprep 150 (SANYO). The lysed cells were centrifuged at 18,000 rpm at 4°C for 
1 hour using J6-HC Centrifuge (Beckman Coulter).  The supernatant of lysed cells 
were passed through 0.45 μm filter and then loaded onto a Glutathione Sepharose 4B 
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column. After finishing loading, the column was washed with at least 10 column 
volume of lysis buffer. The protein was eluted with 20 mM reduced glutathione 
was loaded back onto the regenerated Glutathione Sepharose 4B 
column to remove cleaved GST. The protein solution that flowed through the 
Glutathione Sepharose 4B column was further purified as described below.               
  
freshly prepared in lysis buffer. The concentration of eluted GST-fused protein was 
determined with Coomassie Protein Assay kit. PreScission protease was added to 
eluted protein solution and stored at 4°C overnight. All purification steps were 
performed at 4°C. 
 
 
2.11.2 Desalting and removal of GST 
  The protein solution was loaded onto a HiPrep Desalting column with 
desalting buffer (20 mM Tris, 100 mM NaCl, 2 mM DTT, pH 8.0). The eluted 
protein solution 
 
2.11.3 Purification of Arl1-GRIP domain (Arl1-GRIP) complex  
2.11.3.1 Purification of Arl1 (residues 14-181) 
After removal of GST, Arl1 was further purified by Superdex-75 gel filtration 
chromatography with gel filtration buffer (20 mM Tris, 100 mM NaCl, 2 mM DTT, 
2 mM MgCl2, pH 8.0). The eluted Arl1 fractions were collected and concentrated to 
final concentration of 12 mg/ml with a VIVASPIN 20 (VIVASCIENCE) (10,000 











            f                             
















Figure 2-1.  Purification of Arl1 (residues 14-181) 
olumn.  




a. Chromatogram of Superdex-75 gel filtration c
oteins markers; lane 1-4: gel filtration fractions from peak 1. 
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2.11.3.2 Purification of GRIP domain (2171-2230) of Golgin-245 
After removing GST with the Glutathione Sepharose 4B column, the GRIP 
domain was also further purified using a Superdex-75 gel filtration column with a gel 
filtration buf 2,  pH 8.0). The 
eluted protein was concentrated to a final concentration of 12 mg/ml. The results of 
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Figure 2-2.  Purification of the GRIP domain (2171-2230) of Golgin-245 
a. Chromatogram of Superdex-75 gel filtration column.  
b. SDS-PAGE (15%) of fractions from peak 1 showing the purified GRIP domain. 




fer (20 mM Tris, 100 mM NaCl, 2 mM DTT, 2 mM MgCl











2.11.3.3 Conversion of Arl1 from GDP- to GTP-bound form 
Since only the GTP-bound form of Arl1 can bind the GRIP domain, purified 
Arl1 must be loaded with GTP or a GTP analogue before the formation of the Arl1-
GRIP complex. The conversion of Arl1 to GTP-bound form was done as described 
(Cherfils et al., 1997) with some modifications. Briefly, 5 mM EDTA (final 
concentration) was added to the concentrated Arl1 to chelate Mg  and the protein 
solution was incubated with calf alkaline phosphatase (5 units per mg Arl1) and 10 
 GDPNP (a GTP analogue) at 4°C overnight. Superdex-75 gel filtration was done 
 
 
   olar ratio of 
rl RIP domain about 1.5:1. 2 mM GDPNP and 10 m  Mg2+ (final 
ixture was incubated 
on ice for 30  
filtration ch  
NaCl, 2 mM DTT,
x were collected and 
concen The Arl1-GRIP complex was concentrated to 10 mg/ml and stored at -
omatogram and SDS-PAGE results are shown in Figure 2-3. 
2+
mM
to separate alkaline phosphatase from Arl1 and the eluted Arl1 was concentrated.  
2.11.3.4 Purification of the Arl1-GRIP complex 
The concentrated Arl1 and GRIP domain were mixed with the m
A 1 to the G M
concentration) were added to the protein mixture. The protein m
 minutes. The Arl1-GRIP complex was then purified by Superdex-75 gel
romatography using a buffer containing 20 mM Tris (pH 8.0), 50 mM
 and 2 mM MgCl2. After the protein purity was checked by SDS-












               
 



















Figure 2-3.   Purification of the Arl1-GRIP complex 
(A). Chromatogramof Superdex-75 gel filtration column. 
(B). SDS-PAGE (15%) of fractions from peak 1 and peak 2. Lane M; proteins 






2.11.4 Purification of the Rab7Q67L-RILP effector domain (denoted hereafter 
         as Rab7-RILPe) complex 
1.4.1 Purification of Rab7Q67L-GTP (denoted hereafter as Rab7-GTP) 
   I on residues 67 was mutated to leucine 
(Rab7Q67L) in the collaborator’s laboratory. Rab7Q67L is capable to bind GTP but is 
unable to hydrolyze GTP, so it remains in the GTP-bound active form. The 
purification of Rab7-GTP was quite similar to that of Arl1 that a lysis buffer 
containing 1 mM GTP was used. Rab7-GTP was purified by Superdex-75 gel 
chromatography using a buffer containing 20mM Tris (pH 8.0), 100 mM 








collected and concentrated to 12 mg/ml (Figure 2-4). 
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Figure 2-4. Purification of Rab7-GTP 
a. Chromatogram of Superdex-75 gel filtration column. 
b. SDS-PAGE (15%) of fraction from peak 1 showing the purified Rab7-GTP. Lane 












2.11.4.2 Purification of the RILPe (residues 241-320) 
After removal of GST, the RILPe was further purified by MonoQ ion-
exchange and Superdex-75 gel filtration columns using the same gel filtration buffer. 
The concentrated pure RILPe was mixed with Rab7-GTP (Figure 2-5). 
 
a. 
                      
   Peak 1 
 
b. 
                      
 
         
                    
c. 
                        M       1         2        3          4         5         6  
 
Figure 2-5.  Purification of RILPe 
gram of MonoQ ion-exchange column. 
gram of Superdex-75 gel filtration column. 
he purified RILPe. Lane M: protein markers; 
 
 
   14kD 
 
   Peak 2 
   62kD 
 47.5kD
32.5kD






c. SDS-PAGE (15%) of peak 2 showing t





2.11.4.3 Purification of the Rab7-RILPe complex 
    The concentrated Rab7-GTP and RILPe were mixed together in the presence 
of 2 mM GTP and 10 mM MgCl2 and incubated on ice for 30 minutes. The molar 
ratio of Rab7-GTP to RILPe was about 1.5:1. The Rab7-RILPe complex was purified 
by Superdex-75 gel filtration chromatography using a gel filtration buffer (20 mM 
, 50 mM NaCl, 2 mM DTT, 2 mM MgCl2, pH 8.0). The purified complex was 
concentrated to 10 mg/ml for crystallization (Figure 2-6). 
 
a. 
                  
Tris
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Figure 2-6. Purification of the Rab7-RILPe complex 
n. 






    
32.5kD 
   25kD 
   14kD 
  6.5kD 
a. Chromatogram of Superdex-75 gel filtration colum
b. SDS-PAGE (15%) of peak 1 and peak 2. Lane M: prot








   Crystallization screens were performed using the hanging-drop method with 
Hampton 24-well plastic plates at 20°C. The initial screens were carried out using 
Hampton crystallization screen kits.  Typically, 1 μl protein solution and 1 μl 
reservoir solution were mixed for screening. The conditions under which the initial 
hits were obtained were optimized to get diffraction-quality crystals. The crystals 
were cryoprotected with cryoprotectants and flash-frozen in liquid nitrogen for data 
ollection. The optimized crystallization conditions and cryoprotectants for the 
crystals of the Arl1-GRIP complex, Rab7-GTP and Rab7-RILPe complex are listed in 
Table 1. 
 
2.13 Data collection 
   X-ray diffraction data were collected at 100K using synchrotron radiation. 
Data for the Rab7-GTP crystal were collected at beamline 40B2, Spring-8, Japan 
while those for the Arl1-GRIP complex and the Rab7-RILPe complex were collected 
SY, Hamburg, 
erm ata of the Arl1-GRIP complex were processed using DENZO and 
SCALEPACK (Otwinowski, 1993). Data for Rab7-GTP and the Rab7-RILPe 
comp  processed using MOSFLM and intensities were reduced and scaled to a 
unique set of reflections using SCALA (CCP4 (Collaborative Computational Project 
The statistics for data collection and processing are summarized in 
c










                    
    
Table 1.  Summary of crystallization conditions and cryoprotected buffers 
                                               crystals 
    
 
 Arl1-GRIP   Rab7-GTP Rab7-RILPe  
    
         Initial  
  crystallization    
screen conditions 
 
20% (w/v)  
PEG 3350,  
200 mM KSCN 
30% PEG 2000 
monomethyl ether, 
0.1 M Sodium 
Acetate,  pH 4.6, 0.2 
 






  O ized 
crystallization 
  conditions 
 
PEG 3350,  
200 mM KSCN, 
100 mM Tris,  
pH 8.0 
monomethyl ether, 
200 mM Ammonium 
Sulfate, 100 mM 
MES, pH 5.5 
Sulfate, 0.5% 
polyvinylpyrro-
lidone K15, 100 mM 
HEPS, pH 7.6 
ptim





PEG 3350,  
200 mM KSCN, 
100 mM Tris,  
pH 8.0, 20% 
26~30% PEG 2000 
monomethyl ether, 
200 mM Ammonium 
Sulfate, 100mM 
MES, pH 5.5,  
2.5 M Malonic acid, 
pH 7.4  
glycerol 10% glycerol 









Table 2.  Statistics tion a g  
ystals Arl1- GTP Rab7-RILPe 
 of data collec nd processin
Cr GRIP Rab7-
Space group P1 P1 P6522 
Unit cell dimensio  ns   
a (Å) 42.78 93.13      56.69 
b (Å) 86.51    93.13      56.77
c (Å) 87.80 74.51  132.82     
α (˚) 118.90   71.50    90.00    
β (˚) 96.89     71.71    90.00   
γ (˚) 97.57 77.74 120.00 
Highest resolution .3  (Å) 2 1.9 3.0 
Molecules in asym nit 4 Arl Pe metric u 1-GRIP 4 1 Rab7-RIL
Unique reflections 5526 9 61851 7279 
Redundancy 3.1 (2 (11.4) .9) 1.8 (1.8) 11.3 
Completeness (%) .1  100 (100)  97 (91.9) 94.5 (94.5)
Rmerge (%) .5 (3 .2) 9.7 (42.9) 7 9.6) 5.9 (35
I/δ 6.7 (2 2.0) 6.6 (1.8) .4) 5.2 (
Values in parenthe te the spec e highest resolution shell. 
a |Ij-<I>|/∑Ij, where Ij is the intensity of an individual reflection, and <I> is 
e intensity of that reflection.   
 








2.14 Structure determination 
.14.1 Structure of the Arl1-GRIP complex 
The structure of Arl1-GRIP complex was determined using molecular 
7). The mouse Arl2 without 
G  code:1KSG) (Hanzal-B 2002 s a The 
f of molecular replac nt are shown . The initial model was 
refined by rigid body, stimulated annealing, individual B-factor and energy 
m ent using CN nger et a 8) with th ned non-
crystallographic symmetry (NCS) applied throughout the refineme restrained 
NCS was used in CNS refinement to increase the o on-to-par io. Also, 
the test set (Rfree) was introduced into the refine monitor idate the 
model refinement. The initial Sigm hted 2F  Fo-Fc difference Fourier 
m were calculated in CNS af imization refinement to r  electron 
densities corresponding to GDPNP and GRIP d ins. The electron density of 
G D 2+ were fitted into th ty 
u   (Jones et a ) and ref CNS. Th el of GRIP 
d rtially built using p switch plemented in RESOLVE 
( The sequence oma ed u omatic 
residues su ine and ph  m
model building and CNS refinement, the water molecules were added to and deleted 
from the model automatically using CNS.  At each round of refinement, the geometry 
o




replacement with AMoRe (Navaza and Saludjian, 199
TP (PDB ayer et al., ) was used a search model. 
inal solutions eme  in Table 3
inimization refinem S (Bru l., 199 e restrai
nt. The 
bservati ameter rat
ment to  and val
aA-weig o-Fc and
aps ter min eveal the
oma
DPNP was clearly identified. G PNP and Mg e electron densi
sing the program O l., 1991 ined in e mod
omain was pa rime-and-  mode im
Terwilliger, 2000). s of GRIP d ins were trac sing the ar
ch as tyros enylalanine as arkers. After multiple rounds of 




Table 3. The final solutions of molecular replacement for the Arl1-GRIP 
complex. 
γ (˚) Tx Ty Tz CC_Fa RfacbTable α (˚) β (˚) 
SOLUTIONF1 102.66  11.06   159.09  0.229  0.632   0.695 48.9 50.1 
SOLUTIONF2 276.13  141.19  158.39 0.003  1.001  0.999   48.9 50.1 
SOLUTIONF3 97.08    41.08   10.44   0.750  0.314   0.875   48.9 50.1 
SOLUTIONF4 250.14  163.09  289.94 0.331  0.6450  0.214 48.9 50.1 
aCC_F: is the correlation coefficient between the observed amplitudes for the crystal 
and the calculated amplitudes for the model. 
calculated amplitudes for the model. 
bRfac is the classic R factor between the observed amplitudes for the crystal and the 
 
 
Table 4. The final solutions of molecular replacement for Rab7-GTP. 
Table α (˚) β (˚) γ (˚) Tx Ty Tz CC_F
 
a Rfacb
SOLUTIONF1 320.63  146.15  51.73   0.545  0.544   0.941  52.1      50.2 
SOLUTIONF2 304.77  31.70   220.82 0.990  0.992   0.006   52.1      50.2 
SOLUTIONF3 313.67  147.81  41.91   0.066  0.063   0.428  52.1      50.2 
SOLUTIONF4 293.07  32.93   236.58  0.518  0.518   0.486 52.1      50.2 
aCC_F: is the correlation coefficient between th  observed amplitudes for the crystal 
and the calculated amplitudes for the model. 
e
bRfac is the classic R factor between the observed amplitudes for the crystal and the 
calculated amplitudes for the model. 
 
 
Table 5. The final solution of molecular replacement for the Rab7-RILPe 
complex. 
Table α (˚) β (˚) γ (˚) Tx Ty Tz CC_Fa Rfacb
SOLUTIONF 28.35    85.12 57.33   0.709  0.928   0.195  49.5      47.6 
aCC_F: is the correlation coefficient between the observed amplitudes for the crystal 
and the calculated amplitudes for the model. 
bRfac is the classic R factor between the observed amplitudes for the crystal and the 




(Murshudov et al., 1997).  The refinement statistics of this structure are summarized 
in Table 6. 
c s ent using 
9 t D de: ) 
a
c
imulated annealing, individual B-factor and energy minimization refinements in 
NS (Brunger et al., 1998) using restrained NCS. The difference Fourier maps of 
yp
u  T g
n e u e a  
t   β  
i
d
ed with Procheck (Laskowski et al., 1993). The 
nal round of the refinement was carried out with REFMAC5.0 (Murshudov et al., 
2.14.3 Structure of the Rab7-RILPe complex. 
rch model. The final solution of molecular 
 
2.14.2 The structure of Rab7-GTP  
 The stru ture of Rab7-GTP was olved by molecular replacem
AMoRe (Navaza and Saludjian, 19 7) with he mouse Rab5c-GTP (P B co 1HUQ
s a search model. The final solutions are shown in Table 4. The initial model 
ontaining four molecules in the asymmetric unit was refined by rigid body, 
st
C
2Fo-Fc and Fo- th A weights were cal ted to trace Fc wi Sigma cula the pol eptide 
chain of Rab7 sing the program O(Jones et al., 1991).  he sequence ali nment 
between Rab7 a d mRab5c was us d as a g ide to correct th  model from mR b5c to
Rab7.   
The swi ch II region was modified and the loop between α3 and 5 was
nserted according to the difference Fourier maps. Water molecules were added and 
eleted automatically after multiple rounds of model building and CNS refinement. 
he geometry of the model was checkT
fi
1997).  The refinement statistics of Rab7-GTP structure are summarized in Table 6. 
 
 
The structure was solved using AMoRe (Navaza and Saludjian, 1997) with 
ab7-GTP described above as a seaR
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replacement is shown in Table 5. The initial model containing just one Rab7-GTP 
was refined by rigid body, stimulated annealing, and energy minimization refinement 
 CNS (Brunger et al., 1998). Rfree was applied in all the CNS refinements. The 
 and Fo-Fc maps were calculated to find 
in
SigmaA-weighted difference Fourier 2Fo-Fc
out the electron densities for RILPe. The model of RILPe was manually built with the 
program O (Jones et al., 1991) and the sequence of RILPe was traced based on 
residues containing long side chains such as methionine and arginine. After multiple 
rounds of model building and refinement without B-factor refinement as described 
above, the solvent molecules were included automatically and checked with visual 
inspection of the electron densities. The final round of the refinement was carried out 
with REFMAC5.0 (Murshudov et al, 1997). The refinement statistics of the structure 





Table 6. Refinement statistics  
Structures  Arl1-GRIP Rab7-GTP Rab7-RILPe 
Resolution range (Å) 20-2.3 20-1.9 20-3.0 
Used reflections 42731 59931 6904 
Total atoms 7380 6258 2048 
Proteins atoms 6980 5623 2015 
GTP or GDPNP molecules 4 4 1 
Mg2+ atoms 4 4 1 
Ordered water molecules 268 503 34 
Rwork (%)a 24.6 (33) 24.3 (32) 26.8 (28) 
Rfree (%)b 26.0 (36) 25.0 (34) 27.8 (35) 
Root mean square deviation from ideal values 
Bond length (Å) 0.011 0.018 0.009 
Bond angle (˚) 1.700 2.153 1.682 
Ramachandran plot 
Most favored regions (%) 88.7 91.1 78.6 
Additional allowed regions (%) 9.7 8.9 17.0 
Generously allowed regions (%) 1.5 0 4.4 
Disallowed regions (%) 0.1 0 0 
Values in parentheses indicate the specific values in the highest resolution shell. 
aRwork = ∑||Fo| - |Fc||/∑|Fo|, where Fo denotes the observed structure factor 
amplitude, and Fc denotes the structure factor amplitude calculated from the model. 
bRfree is as for Rwork but calculated with 5.0 % of randomly chosen reflections 





                                             Chapter 3 
                      Structure of the Arl1-GRIP complex 
 
3
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 array rather than a three-helix bundle, with one side of the array for 
dimerization and the other side to interact with Arl1-GTP. The homodimer of GRIP 
domains forms a six-helix bundle in a parallel fashion, interacting with the 
noncrystallographic symmetry related homodimer in a head-to-tail manner (Figure 3-
1b and 3-1c). There are very few interactions between the NCS-related Arl1 
molecules and no contacts in the Arl1-GRIP heterodimer. In contrast, GRIP domains 
interact extensively in the homodimer interface while there are few contacts between 
NCS-related GRIP domains.  
 
3.1.2 Arl1-GRIP domain interface 
The structure shows that Arl1 and the GRIP domain share an extensive 
interface. The interaction between Arl1 and the GRIP domain buries a pairwise 
accessible surface area of 1272 Å2. The GRIP domain interacts with Arl1 via its first 
two helices α1 and α2. Arl1 interacts with the GRIP domain mainly through its 
switch II region, with additional residues from the switch I and interswitch regions 



























Figure 3-1. Structure of the Arl1-GRIP complex.  
a. Stereo view of a representative portion of the Fo-Fc electron density map 
(contoured at 1.2 σ) covering helices α1 and α2 of the GRIP domain. The map was 
calculated with phases from Arl1 molecules only. The percentages of the scattering 
matter contributed by the GRIP domain and the Arl1 molecule are 28% and 72% 
respectively. The figure was produced by POVScript (Fenn et al., 2003) and Raster3D 
(Merritt and Bacon, 1997). b. The Arl1-GRIP heterodimeric dimer formed by Arl1 
molecules A (green) and C (yellow), and the GRIP domains E (dark green) and G 
(orange). Switch I, interswitch and switch II of Arl1 are shown in cyan, blue and red 
respectively. GDPNP molecules are shown as stick models and Mg2+ as cyan spheres. 
c. Top-view of the Arl1-GRIP heterodimeric dimer. The molecules are rotated 90° 
relative to the view in (b).  
The figures in b and c are produced by Molscript (Kraulis, 1991) and 
Raster3D (Merritt and Bacon, 1997). If not stated, the figures in the following were 




the switch II region of Arl1 confers the specificity of its interaction with the GRIP 
omain (Lu et al., 2003). The recognition specificity between Arl1 and the GRIP 
domain is predominantly achieved through hydrophobic interactions, with two 
additional hydrogen bonds (Figure 3-2a). The surface groove on Arl1 which interacts 
with the GRIP domain is composed mainly of hydrophobic amino acids (I49, F51, 
Q64, W66, Q71, S73, I74, Y77, C80 and Y81). These residues are located in the 
switch and interswitch regions and most of them are highly conserved in Arls or Arfs 
except for residues I49, S73, and C80 (Figure 3-3a). Residue C80 is only present in 
Arl1 but not other Arls or Arfs (Figure 3-3a).  Mutation of C80 to a histidine which is 
highly conserved in all Arfs significantly reduced the ability of Arl1 to interact with
e GRIP domain of Golgin-245 (Lu and Hong, 2003), suggesting C80 may play an 
The surface area of the GRIP domain which interacts with Arl1 consists of 
hydrophobic residues Y2177, V2181, M2194, V2197, V2201, with the additional 
polar and charged residues T2173, E2174, E2176, T2193 (Figure 3-2b). Most of 
these residues are conserved in GRIP domains across species (Figure 3-3b). Close 
inspection of the structure shows that residue Y2177, the only invariant aromatic 




important role in the interactions of Arl1 with the GRIP domain. C80 is situated at the 
edge of the hydrophobic interface and contacts V2197 of GRIP domain via 
hydrophobic interactions (Figure 3-2a). Replacement of this residue with a large 
polar amino acid such as histidine may cause steric hindrance and/or destabilizing of 
the hydrophobic interface, thus weakening the binding of Arl1-GTP to the GRIP 
domain. These unique interactions observed in the complex structure showed that 






Figure 3-2. Arl1-GRIP domain and 
a. Stere
 
GRIP-GRIP domain interfaces  
o diagram of the Arl1-GRIP domain interface. The GRIP domain (chain E) is 
shown in orange and the Arl1 molecule (chain A) in yellow. Switch I, switch II and 
interswitch regions of Arl1 are shown in cyan, red and blue, respectively and the rest 
of Arl1 in yellow. Residues involved in the Arl1-GRIP domain interactions are shown 
in stick models Hydrogen bonds are shown as a black broken line. b. Stereo diagram 
of the GRIP-GRIP domain interface. The GRIP domains of chain E and G are shown 
in green and yellow respectively. Residues involved in the GRIP-GRIP domain 
interactions are shown in stick models and labeled in dark green and chocolate for 







Figure 3-3. Sequence alignments of Arls and GRIP domains.  
a. Alignment of amino acid sequences of rat Arl1, S. cerevisiae Arl1, mouse Arl2, and 
mouse Arl3, and mouse Arf1. Secondary structures for the rat Arl1 are shown on the 
top. The switch I, II and interswitch regions are marked with cyan, red and blue (dash) 
lines respectively. Residues involved in interactions with the GRIP domains are 
marked as “ # ”.  Variant residues are shown in white letters, the similar residues in
red and others in black. Residues with similarity between 0.7 and 1.0 as defined in 




conserved GRIP domain of human Golgin-245, human Golgin-97, mou
S.cerevisiae Imh1p, human GCC1 (GCC88) and mouse GCC185. The secondary 
structure for the GRIP domain of human Golgin-245 is shown. Mutated residues 
involved in GRIP domain dimerization and interactions with Arl1-GTP are marked as 






residues located in the switch II region of Arl1. The side chain of Y2177 fits tightly in 
a hydrophobic pocket formed by the side chains of I74, Y77, C80 and Y81 of the 
switch II region in Arl1.  In addition to the hydrophobic interactions, the hydroxyl 
group of Y2177 is hydrogen-bonded to that of Y81 of the switch II region in Arl1. 
The nature of the interactions implies that replacement of Y2177 by any other non-
aromatic residue would reduce the binding of GRIP domain to Arl1 significantly. This 
observation explains the findings that replacement of Y2177 with Ala in the GRIP 
domain of Golgin-245 abolished its Golgi targeting mediated by the interactions 
between Arl1-GTP and its GRIP domain whereas substitution of Y2177 for 
phenylalanine had little effect (Barr, 1999; Kjer-Nielsen et al., 1999a) (Figure 3-4b). 
Similar results have been obtained by mutation of residue Y697 of Golgin-97 
(counterpart of Y2177 of Golgin-245) to Ala (Lu et al., 2003). In addition to contacts 
with Y2177, the switch II region also interacts with residues located at the helix α2 of 
the GRIP domain (Figure 3-2b). Y77 interacts with V2201 while residues C80 and
81 make multiple contacts to the side chains of V2197 and T2193 via hydrophobic 
he Arl1-GRIP domain 
terface are made between residues located in the switch I and interswitch regions 
nd the residues located in the helix α1 of the GRIP domain (Figure 3-2a). 
Specifically, the side chain of I49 of the switch I interacts with that of E2176. In the 
 
Y
and van der Waals interactions. The hydroxyl group of Y77 makes a hydrogen bond 
with the OE1 atom of E2174 in the GRIP domain. The extensive interactions 
contributed by the switch II region to the Arl1-GRIP domain interface suggest that the 
switch II region may play an indispensable role in recognition of the GRIP domain. In 
line with these observations, replacement of the whole switch II region of Arl1 with 
Arf1 corresponding residues completely abolished the interaction of Arl1-GTP with 





interswitch region, F51 makes a strong hydrophobic interaction with M2194, and 
contacts E2184 via a van der Waals interaction. Both Q64 and W66 interact with 
residue E2190 via hydrophobic and van der Waals interactions.  
In order to probe the functions of residues involved in Arl1-GTP and the GRIP 
domain interactions in Golgi targeting, structure-guided mutagenesis was performed 
in the collaborative laboratory. Mutations of residues V2181, T2193, M2194 and 
V2197 to Ala in the GRIP domain of Golgin-245 abolished its Golgi targeting 
(Figure 3-4a and 3-4c). These observations combined with the earlier mutational 
studies on residue Y2177 (Kjer-Nielsen et al., 1999a; Kjer-Nielsen et al., 1999b; Lu 
et al., 2003) suggest that the specific interactions between Arl1 and the GRIP domain 
are essential for Golgi localization of Golgins containing the GRIP domain. 
 
 
3.1.3 GRIP-GRIP domain interface 
The structure shows that GRIP domains form a tight homodimer. There are 
two homodimers (E:G and H:F) of GRIP domains in the asymmetric unit. Because the 
E:G dimer is very similar to the H:F dimer (with pairwise r.m.s.d of 0.2 Å), the E:G 
dimer (Figure 3-1b) has been chosen for illustrating the GRIP-GRIP domain interface. 
The interactions in the E:G dimer interface are predominantly hydrophobic in nature 
with a buried accessible surface area of 1880 Å2. Strikingly, all three α-helices of 
GRIP domain are involved in dimerization.  
The surface area of the GRIP domain for dimerization is composed of four 
aromatic amino acids (F2175, F2183, Y2185, and F2204), seven hydrophobic 




Figure 3-4. Cellular localization and yeast two-hybrid assays of Golgin-245 GRIP 
a. Cellular localization of representative mutants, including wt (Golgi), M2186A, and 
Δα
and lower panels respectively. b. Effects
domain mutants.  
V2197A and 3. GFP-tagged GRIP domain mutants and GM130 are shown in upper 
 of mutations on the GRIP domain 
dimerization examined by yeast two-hybrid assays. “∗” and “•” indicate residues 
located
scores of the dimerization and Golgi distribution of GRIP domain mutants. “+” 
cytosolic distribution. Mutations of E2190A, D2206A and ΔCt serve as negative 
elf 
interaction of both its GRIP domain and coiled-coil regions. “+” and “-” indicate 
positive and negative interactions, respectively, in yeast two-hybrid assays. These 
experiments were performed by Dr. Lu Lei in Prof. Hong Wanjin’s laboratory. 
 in the Arl1-GRIP and GRIP-GRIP domain interfaces respectively. c. The 
indicates dimerization or Golgi localization. “-” indicates no self-interaction or 
controls. d. Golgin-97 forms homodimer in a parallel manner through the s
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residues (R2179, K2211) and one polar residue (Q2208). These residues in GRIPE 
make multiple van der Waals and hydrophobic interactions with the same set of 
residues in GRIPG (where subscript E and G are designated for the chains E and G of 
GRIP domains respectively). 
The dimer interface is shown in Figure 3-2b. Specifically, beginning from the 
N-terminal of helix α1, residue F2175E makes strong hydrophobic interactions with its 
2-fold NCS-related counterpart F2175G. R2179E, a conserved residue in the GRIP 
domain, interacts with L2202G and F2204G via hydrophobic interactions with its 
methylene group stacking against the aromatic ring of F2204G. In support of this 
observation, replacement of K699 (corresponding to R2179 of Golgin-245) to Ala in 
Golgin-97 abrogated the Golgi targeting of the mutant protein in the earlier studies 
(Lu et al., 2003), underscoring the importance of this residue in the GRIP domain 
dimerization. L2182E contacts L2202G and F2204G, respectively while residue F2183E 
interacts with L2212G and the aliphatic side chain of Q2208G. A conserved Y2185E 
makes strong hydrophobic interactions with its 2-fold NCS-related counterpart 
Y2185G, and M2186G, suggesting this residue may play an important role in 
dimerization. M2186E and M2187E make multiple contacts with Y2185G, I2198G, 
I2212G and K2211G via van der Waals and hydrophobic interactions. I2198E of helix 
α2 interacts with M2186G via van der Waals interactions while L2202E, the second 
invariant residue in the GRIP domain across species, makes a strong hydrophobic 
interaction with L2182G. In addition to the intermolecular interactions, L2202E makes 
close intramolecular contacts with residue F2204E which in turn makes stacking 
interactions between its aromatic ring and the aliphatic side chain of R2179G. The 
methylene group of K2211E of helix α3 packs against the side chain of M2187G. 
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I2212E is situated in the middle of α3, making multiple contacts with F2183G, 
M2186G and M2187G.  
The extensive dimer interface and involvement of some highly conserved 
residues in the GRIP domain suggest that the homodimer of GRIP domains may 
function as a structural unit for interaction with Arl1 to mediate Golgi localization of 
Golgin-245. Previously, it has been shown that substitution of Y2185 for Ala in 
Golgin-245 resulted in the loss of Golgi targeting of the mutant protein (Kjer-Nielsen 
et al., 1999a) but the mechanism of how Y2185 affects Golgi targeting was not 
revealed. These observations from the complex structure suggest that change of 
Y2185 to Ala may disrupt the GRIP domain dimerization, hence affecting the Golgi 
localization of Golgin-245. Additional mutations on residues involved in the GRIP-
GRIP domain interactions were performed to probe their effects on the Golgi 
targeting. As predicted, Golgin-245 mutants with mutations of F2183, M2186, I2198, 
L2202, F2204 and I2212 to Ala were not found to be Golgi-associated (Figure 3-4a 
and 3-4c). Residues F2183, Y2185, M2186, I2198, L2202, F2204 and I2212 have no 
direct contacts with Arl1-GTP, but substitutions of these residues with Ala still 
abolished the Golgi targeting of Golgin-245. One likely explanation for this 
observation is that mutations disrupting the GRIP domain dimerization also abolish its 
interaction with Arl1-GTP, thus affecting its Golgi localization. Moreover, removal of 
helix α3 of the GRIP domain and the further C-terminal tail (mutant ∆α
yeast two-hybrid assays. Mutations of F2183, Y2185, I2198, L2202, F2204 and I2212 
3) abolished 
the Golgi targeting of Golgin-245 whereas truncation of the C-terminal tail alone 
(mutant ∆Ct, residues 2222-2230) had no such effect (Figure 3-4a and 3-4c).  To test 
the effects of the GRIP domain mutations on dimer formation, collaborators examined 
those GRIP domain mutants which have been found to abolish Golgi targeting by 
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to Ala and mutant ∆α
idues located in the Arl1-GRIP domain interface, 
such as
3 were found to abolish the GRIP domain self-interaction, while 
mutant ∆Ct and Ala mutations on res
 Y2177, V2181, T2193 and M2194 and V2197 have no effect on the GRIP 
domain dimerization (Figure 3-4b and 3-4c). Although mutant M2186A, 
unexpectedly, showed self-interaction in yeast two-hybrid assays, it did not interact 
with Arl1-GTP and failed to target the Golgi apparatus (Figure 3-4a and 3-4c). The 
self-interaction of M2186A probably reflects oligomerization and/or aggregation 
rather than productive dimerization. Such oligomerization and/or aggregation could 
not create an interacting surface for Arl1-GTP, thereby leading to defective Golgi 
targeting. Collectively, these results imply that the integrated GRIP domain dimer is 
the structural and functional unit which is essential for the interaction with Arl1 and 
thereafter Golgi targeting. 
The observations that the GRIP domain forms a parallel homodimer with all 
three helices involved are independently supported by the yeast two-hybrid studies on 
Golgin-97 in Prof. Hong Wanjin’s laboratory. As shown in Figure 3-4c, Golgin-97 
interacts with itself well. Both the GRIP domain and the coiled-coil region can 
independently self-interact, suggesting there exist two independent dimerizing 
interactions, one mediated by the GRIP-GRIP domain interaction, while the other is 
mediated by the coiled-coil:coiled-coil interaction. Consistent with this, the GRIP 
domain of Golgin-97 did not interact with the coiled-coil region (Figure 3-4d). These 
results suggest that Golgin-97 (and likely Golgin-245) forms an extensive parallel 
dimer with the dimerized GRIP domains interacting with Arl1-GTP to mediate Golgi 





3.1.4 Conformational switch of Arl1 and GRIP domain binding   
It has been shown that Arl1-GTP recruits the GRIP domain to the Golgi 
membrane whereas the Arl1-GDP has no such activity (Lu et al., 2003).  To probe the 
structural basis of conformational switches in Arl1 upon the GTP binding and the 
effects on GRIP domain binding, the structure of Arl1 in the complex of Arl1-GRIP 
complex was compared with that of the S. cerevisiae Arl1 (scArl1) in the GDP-bound 
form (Amor et al., 2001) (PDB code:1MOZ), mouse Arl3 (mArl3) in the GDP-bound 
form (Hillig et al., 2000) (PDB code:1FZQ) and mouse Arl2-GTP (mArl2) in the 
complex of Arl2-GTP/PDEδ (Hanzal-Bayer et al., 2002) (PDB code: 1KSG). All 
three structures are very similar (pairwise r.m.s.d. of 0.4 Å) with the largest deviations 
in the switch regions.  
As previously observed in the GTP/GDP structural cycles of Arf1 (Amor et al., 
1994; G
posed by the switch I region (Figure 3-5a and 3-5b). The  
reasley et al., 1995; Goldberg, 1998) and Arf6 (Pasqualato et al., 2001), the 
switch I region of Arl1 undergoes a dramatic conformational change upon GDPNP 
binding (Figure 3-5).  In the GDP-bound forms of scArl1 and mArl3, the switch I 
region is folded into an additional β strand (β2E) which forms part of the central β 
sheet, anti-parallel to the strand β2 (Hillig et al., 2000; Amor et al., 2001). The top of 
the switch I region would extend out and insert between helices α1 and α2 of the 
GRIP domain (Figure 3-5a and 3-5b), thus posing severe steric hindrance in the 
GRIP domain binding site on the Arl1 surface groove to prevent the GRIP domain 
binding.  In the GTP-bound state of Arl1, the additional β strand (β2E) is unfolded to 
take T48 close to the nucleotide, where it plays its canonical role in magnesium and γ-
phosphate coordination, thus effectively relieving the steric blockage on the GRIP 
















Figure 3-5. Structural comparisons of Arl1-GTP in the Arl1-GRIP complex with 
other Arls.   
a. Stereo view of superpositions of Arl1-GTP and S. cereceviae Arl1-GDP (scArl1).  
The GRIP domain (chain E) is shown in orange, Arl-GTP molecule (chain A) in 
yellow and scArl1 in green. The switch I and II regions in Arl1-GTP are shown in 
cyan and red respectively, and that of scArl1 in blue and magenta respectively. 
GDPNP and Mg2+ from Arl1-GTP are shown as stick models and a cyan sphere 
respectively.  Residues T48 (Arl1-GTP) and T49 (scArl1) are shown as ball-and-stick 
models. b. Stereo view of superpositions of Arl1-GTP and mouse Arl3-GDP (mArl3). 
The coloring scheme is as in (a) except that mArl3 is shown in spring green. T48 of 
mArl3 is shown as a ball-and-stick model. c. Stereo view of superpositions of Arl1-
GTP and mouse Arl2-GTP (mArl2). The coloring scheme is as in (a) except that 
mArl2 is shown in light sea green. Only T48 of Arl1-GTP is shown as a ball-and-stick 




conformation of the switch II region, which contributes most of the specificity for the 
GRIP domain binding (see above), is also changed upon GDPNP binding but to a less  
extent compared to the switch I region.  In the GDP-bound form of both scArl1 and 
mArl3, the upper part of the helix in the switch II region would clash with the helix α2 
of GRIP domain and most of the residues involved in interactions with GRIP domain 
would not be accessible, thereby preventing their binding to the GRIP domain 
(Figure 3-5a and 3-5b).  In the GTP-bound form of Arl1, the axis of this helix is 
shifted by 15°. As the consequence of this shift, the whole switch II region moves 
toward the central β-sheet (Figure 3-5a and 3-5b). The conformational change not 
nly enables G70 of 67DxGGQ71 motif in the switch II region to adopt its canonical 
2
ange results in the N-terminal region of 
Arl2 forming an amphipathic helix exposed to the solvent.  This helix has been 
proposed to interact with membrane as observed with Arf proteins (Boman et al., 
1995; Goldberg, 1998). In this crystal structure, the N-terminal 13 residues have been 
removed to facilitate the crystallization. However, given the fact that the fold of the 
Arl1-GTP is strikingly similar to that of other members of Arf family, it is tempting to 
speculate that the N-terminal region of Arl1 may also be folded into a solvent-
exposed helix, therefore allowing Arl1 to anchor on the Golgi membrane by the 
myristoylation of residue G2 in the N-terminus(Antonny et al., 1997). 
o
role in the coordination of the γ-phosphate, but also makes it possible for the α  helix 
of GRIP domain to bind the switch II region.  
The switch regions of Arl1-GTP are essentially the same as those in Arl2-GTP 
although they bind different effectors (Figure 3-5c). In the GTP-bound form of Arl2, 
the interswitch region (residues 51-67) undergoes a β-sheet register, with β-strands β2 
and β3 sliding by two residues relative to the remaining β-sheet (Hanzal-Bayer et al., 




3.2.1 Structural comparison of Arf proteins in complex with their effectors 
In addition to the structure of Arl1-GRIP complex, three other structures of 
Arf proteins in complex with their effectors, Arl2-PDEδ (phosphodiesterase δ subunit)
(Hanzal-Bayer et al., 2002), Arf1-GAT (GGA GAT domain) (Shiba et al., 2003) and 
Arf6-CTA1 (cholera toxin A1 subunit) (O'Neal et al., 2005b) have been solved. Arf1 
has been shown to interact with the GAT domain of GGAs, adaptor proteins with a 
critical role in vesicular transport (Shiba et al., 2003). Our crystal structure of the 
Arl1-GRIP complex shows similar interactions in which the first two helices α1 and 
α2 (helix-loop-helix) of GRIP domain interact with both the switch and interswitch 
regions (Figures 3-2a and 3-6). The crystal structure of Arf1-GTP complexed with 
the N-terminal helix-loop-helix region of GAT
 
 domain shows that both the switch and 
intersw
d forms of Arf 
itch regions of Arf1 are involved in interactions with the GAT domain, and 
that the helix-loop-helix motif of GAT is positioned directly against the interswitch 
region of Arf1 (Figure 3-6). The crystal structure of Arl2-GTP in complex with its 
effector PDEδ shows that the β7 from the β sheet of PDEδ primarily contacts the β2 
of the interswitch region of Arl2, thus forming a parallel intermolecular β-sheet, 
similar to that of Ras-effector interactions (Figures 1-6 and 3-6). Other interactions 
between Arl2-GTP and PDEδ are also observed in the switch and interswitch regions 
(Hanzal-Bayer et al., 2002) (Figure 3-6). The interface of Arf6 with its effector is 
more extensive than those in the other three structures with helices and β-strand of 
CTA1 involved in the interactions with Arf6.  Like Arl1, Arl2 and Arf1, Arf6 uses 
switch and interswitch regions to interact with CTA1 (O'Neal et al., 2005a).  
Comparison of the structures of Arf proteins in complex with their effectors 
reveals some common structural features.  First, only the GTP-boun
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cause steric clashes between the switch regions of Arf proteins and their effe
, the interfaces between Arf proteins and their effectors are predominantly 
hydrophobic in nature with few hydrogen-bonding interactions. Third, like other small 
GTPases, the Arf proteins interact with their effectors using switch and interswitch 
regions. The involvement of the switch and interswitch regions explains the 
specificity of the GTP-bound forms of these small GTPases for recognizing their 
respective effector molecules. 
Arl1-GRIP domain and Arf1-GAT domain seem to share the same interaction 
mode in which Arf proteins contact the swapped N-to-C-terminal helix-loop-helix 
motifs. This interaction mode is also seen in other small GTPases such as Rho 
proteins and their effectors (Panic et al., 2003b) (Figure 1-8).  However, the 
interaction modes of the proteins in the other two compelxes are quite different. PDEδ 
uses the β-sheet structure to interact with Arl2, which is also seen in the interaction 
mode of Ras-effectors (Figure 1-6), while CTA1 uses more extensive structure to 
contact Arf6. This suggests that effectors interact with Arf proteins using diverse 
interaction modes despite the fact that they only contact their effectors using the 











Figure 3-6. Structural comparisons of the Arf proteins in complex with their 
respective effectors Arl1, Arf1, Arl2 and Arf6 are shown in yellow in the same 
orientation. The effector molecules, GRIP domain, GAT domain, PDEδ and CTA1 
are shown in orange. The switch I and II regions are shown in cyan and red 







3.2.2 Specific interaction between Arl1 and GRIP domain 
The structure of the Arl1-GRIP complex provides an explanation why Arl1, 
but not other Arf or Arl proteins, interacts with the GRIP domain of Golgin-245. The 
binding specificity of Arl1-GTP for the GRIP domain is mainly conferred by the 
residues in the switch II region with additional residues from the switch I and 
interswitch regions. The combined interaction of the residues located in the switch II 
region with GRIP domain explains mechanistically the earlier mutational studies of 
the Arl1 switch II region in that collective action of these residues are more important 
than any individual residue (Lu et al., 2003). Since residues Q64, S73, Y77 and C80, 
which are located in the switch II and interswitch regions and involved in the Arl1-
GRIP domain interface, are specifically present in Arl1 of diverse species but not in 
other Arf proteins, the specificity of Arl1 versus other Arf proteins for the GRIP 
domain recognition is likely conferred by these four residues. Residue C80 is only 
present in Arl1 while this residue is replaced by a polar residue (such as Asn, Ser and 
His) in other Arls. C80 is located in the hydrophobic interface in the structure of the 
Arl1-GRIP complex. The structural data combined with the earlier mutational studies 
on this residue suggest that this residue at least confers partial specificity of Arl1 
versus other Arls for the GRIP domain recognition. 
It has been shown previously that the GDP-bound Arl1 has no or little activity 
transition of the inactive GDP-bound form to the active GTP-bound form of Arl1 
catalyzed by the GEF results in dramatic conformational changes of the switch 
regions, thus effectively relieving the steric hindrance imposed by the switch regions 
of binding to the Golgi membrane and is mainly cytosolic (Lu et al., 2001). Structural 
comparison of the GDP- and GTP-bound Arl1 revealed that both the switch I and 
switch II regions prevent GRIP domain binding to Arl1-GDP (see above). The 
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and allowing the high-affinity binding of GRIP domain to Arl1-GTP.  Furthermore, 
the GD
3.2.3 Mechanism of recruitment of Golgins containing GRIP domain to the Golgi 
Kjer-Nielsen et al., 1999b). The 
GRIP d
P- to GTP-bound transition of Arl1 also causes the β-sheet register to shift in 
the interswitch region, thereby causing the myristoylated N-terminus to be exposed to 
the cytoplasm so that it can attach to the Golgi membrane. It has been reported in S. 
cerevisiae that Arl3p is required for the normal Golgi localization of Arl1p, 
suggesting that the GEF of Arl1 is regulated by Arl3p and its mammalian homologue 
ARFRP1 (Setty et al., 2003; Jackson, 2003; Panic et al., 2003b). 
 
 The structure shows that Arl1-GTP interacts with the GRIP domain of 
Golgin-245 predominantly in a hydrophobic manner. The nature of the interactions 
suggests that Arl1-GTP recognizes the GRIP domain specifically and directly with the 
switch II region providing the main binding affinity. Mutations which abolished the 
GRIP domain localization have been mapped on the Arl1-GRIP domain interface, 
confirming the earlier findings that the interaction between Arl1-GTP and the GRIP 
domain is essential for Golgi targeting of Golgins containg GRIP domain (Munro et 
al., 1999; Barr, 1999; Kjer-Nielsen et al., 1999a; 
omain is folded into an anti-parellel three-α-helix array that is stabilized only 
by homodimerization. Mutations on residues involved in the GRIP domain 
dimerization are expected to destabilize the three-α-helix array and abolish its ability 
to interact with Arl1-GTP and Golgi targeting.  The mutational studies of residues 
F2183, Y2185, M2186, I2198, L2202, F2204 and I2212, implicated in GRIP domain 




The crystal structure of GRIP domain complexed with Arl1-GTP provides a 
novel understanding in that the GRIP domain dimer is the structural and functional 
unit, which creates two symmetric surfaces on the two distal sides of the dimer for 
interacting with two separate Arl1-GTP molecules.  These two Arl1-GTP molecules 
seem to anchor the GRIP domain dimer effectively onto the surface of the Golgi 
membrane. Consistent with the structural interpretation that the dimer of Golgin-245 
GRIP domain is parallel in nature, we have also established the existence of two 
imerizing regions in Golgin-97 by yeast two-hybrid interaction assays. Golgin-97 
and Golgin-245 are likely parallel homodimer anchored to the Golgi membrane by 
activated Arl1 interacting with their GRIP domains. The structure not only 
mechan
work for 
future studies of Golgin-245, Golgin-97 and other Golgins. 
d
istically explains the previous mutational studies of GRIP domain and Arl1 
but also provides new insight into the molecular basis of the Arl1-GTP mediated 
Golgi targeting, with the supports from the additional structure based mutational 
studies. As predicted, mutation of several residues implicated in the GRIP 
dimerization abolished effectively Golgi targeting.  Taken together, Golgi targeting of 
Golgin-245 (and likely Golgin-97 and other GRIP domain proteins) involves at least 
two coupled events (Figure 3-7).  The first is that Golgin-245 forms a parallel dimer 
mediated by the GRIP domain and likely the coiled-coil region. The dimerization of 
GRIP domain creates two symmetric and independent surfaces for interaction with 
two separate Arl1-GTP molecules, resulting in effective targeting of Golgin-245 to 
the membrane. Such structural arrangement not only makes the association of Golgin-
245 with the membrane stable but also enables the rest of the Golgin-245 dimer 
flexible for any additional interaction and function. The current structural and 





           
 
membrane by Arl1. A schematic model of recruitment of Golgin-245 to the Golgi 
transition catalyzed by an yet unidentified GEF, Arl1-GTP is localized to the Golgi 
GTP recruits Golgin-245 to the Golgi membrane by interacting with its GRIP domain. 
independently dimerized. Each subunit of the GRIP dimer interacts separately with 
Switch I, interswitch, switch II regions and the N-terminal region of Arl1 are colored 
stick models and Mg
Figure 3-7. A schematic model of recruitment of Golgin-245 to the Golgi 
membrane by Arl1. Arl1-GDP is localized to the cytoplasm. Upon the GDP to GTP 
membrane by anchoring its myristoylated N-terminus to the membrane. The Arl1-
Golgin-245 forms a parallel dimer with its coiled-coil region and GRIP domain 
one Arl1-GTP molecule, thus efficiently anchoring Golgin-245 to the membrane. 
in black, blue, magenta and red respectively. GDP and GTP molecules are shown as 
 






                                       
                                         Chapter 4   
   Structures of Rab7-GTP and Rab7-RILPe complex 
 
4.1 Results 
4.1.1 Overall structure of Rab7-GTP 
   The structure of Rab7-GTP in space group P1 was determined by molecular 
replacement (Navaza and Saludjian, 1997) at a resolution of 1.9Å. There are four 
molecules in the asymmetric unit. Similar to the structures of Rab3a and Rab5c 
(Dumas et al., 1999; Merithew et al., 2001), the structure of Rab7-GTP reveals a 
typical Rab GTPase fold with a six-strand β sheet surrounded by α helices (Figure 4-
1a). Although the full-length Rab7-GTP was crystallized, the final model lacks 
s in the extreme N-terminus (residues 1-7) and C-terminus (residues 183-207), 
GTP ( ).  The extended loop structure of the switch II region is also seen 
in the Ypt7-GDPNP and the recently solved Rab11a-GDP and Rab11a-GTPγS 
ructures (Constantinescu et al., 2002; Pasqualato et al., 2004).  
It remains unclear why some Rab proteins prefer this loop structure in the 
itch II region. In Rab3a-GTP and Rab5c-GDPNP structures, The phenyl rings of 
  
residue
suggesting that these two regions are highly flexible in the solution. This result is 
consistent with the previous NMR results, in which the N- and C-terminus of Rab7-
GDP have been shown to be disordered (Neu et al., 1997). When the structure of 
Rab7-GTP is compared with those of Rab3a-GTP and Rab5c-GDPNP, the most 
notable difference lies in the switch II region. The switch II region of Rab7-GTP is an 






Y91 in Rab3a and Y90 in Rab5c in the switch II region faces outside to form a triad 
76 in Rab3a; F58 and W75 in 
Rab5c) in the interswitch region, which is responsible for the plasticity of Rab protein 
ch II 
gion corresponding to Y91 in Rab3a and Y90 in Rab5c is buried in the core 
corresponding phenyl rings of the residues F78 in Ypt7 and Y80 in 
tructure while those of Rab3a and Rab5c 
 
ain of RILP is 
shown in 
structure together with other two residues (F59 and W
structures (Merithew et al., 2001). However, the phenyl ring of F77 in the swit
re
structure. The 
Rab11a also are inserted into the β-sheet s
face outside (Figure 4-1c). It is possible that the orientation of side chain of F77 in 
Rab7-GTP is responsible for the extended loop structure by disturbing the typical 
switch II helical structure.    
 
 
4.1.2 Structure determination of the Rab7-RILPe complex 
Human full-length Rab7-GTP and the Rab7 binding domain of RILP (residues 
241-320) were expressed in E. coli. The complex was formed by mixing the purified 
Rab7 and RILPe and subsequently purified by gel filtration chromatography. The
Rab7-RILPe complex was eluted with a molecular weight that is consistent with a 
Rab7:RILPe molar ratio of 2:2, suggesting the existence of a heterodimeric dimer in 
solution (Figure 2-6). The structure was solved by the molecular replacement method 
using Rab7-GTP as a search model.  The current model has been refined at a 
resolution of 3.0 Å to working and free R factors of 26.8% and 27.8%, respectively 
with good statistics and stereochemistry (Table 6).  A representative portion of the 
initial electron density map in the region of the Rab7 binding dom
Figure 4-2a. All protein main chain torsion angles are located in the 




                              
Figure 4-1. Rab7-GTP structure and structural comparisons with other Rab 
proteins. a. crystal structure of Rab7-GTP. The switch I and switch II are highlighted 
with magenta and red, respectively. The GTP molecule is shown in stick models and 
Mg  as a white sphere. b. Superimposition of Rab7, Ypt7, Rab11a, Rab3a and 
Rab5c. The switch II regions of Rab7, Ypt7, Rab11a, Rab3a and Rab5c are 
highlighted with red, magenta, navy, dimgrey and darkgreen, respectively. The GTP 
molecule is shown in stick model and Mg
2+
e 
hydrophobic triads are same as those in (b). 
2+ as white sphere. c. Superimposition of 
interswitch and switch II regions of Rab7, Ypt7, Rab11a, Rab3a and Rab5c. The 
invariant hydrophobic triads are shown as stick models. The colors of th
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electron density map and are assumed to be disordered, namely residues 186-207 in 
the C-terminus of Rab7 and residues 309-320 in the C-terminal segment of RILPe. 
Statistics of structure determination and refinement are summarized in Table 6. 
 
 
4.1.3 Overall structure of the Rab7-RILPe complex  
 The ribbon diagram of the Rab7-RILPe complex is shown in Figures 4-2b 
and 4-2c. There is one Rab7-GTP plus one RILPe molecule in the asymmetric unit.  
The structure of Rab7 in the complex also contains a central six-strand β-sheet (β1-6) 
flanked by α-helices and is in common with other Ras-like small GTPases (Figure 1-
7). The fold of Rab7 in the complex is very similar to that of Rab7-GTP (Figure 4-2d) 
in which the conformation of the switch II region is an extended loop as described 
above. Despite such high similarity with the Rab7-GTP structure, substantial 
structural differences are observed in the N- and C-terminal regions of Rab7. In the 
structure of Rab7-GTP, the N- (residues 1-6) and C-terminal regions (183-207) are 
disordered.  In contrast, in the Rab7-RILPe complex structure, the N- and C-terminal 
regions extend to residues 3 and 185, respectively. Furthermore, the usual helical 
structure of residues 175-185 is melted into a small β-strand (residues 179-182) to 
form an antiparallel β-sheet with β1 (Figure 4-2d). This small β-sheet is involved in 
interactions with RILPe and may have important functional implications (see below). 
RILPe is folded into a long helix α1 and a short helix α2 connected by a very 
tight loop. Since only helix α1 contacts the Rab7 molecule in the asymmetric unit, 
whereas helix α2 interacts with the crystallographic 2-fold related Rab7, the 
biologically meaningful complex was generated by the application of a 








              
 
Figure 4-2.  Structure of the Rab7-RILPe complex. 
a. Stereo view of a representative portion of the Fo-Fc electron density map 
(contoured at 1.6 σ) covering residues 256 to 263 of the helix α1 in the Rab7 binding 
domain of RILP. The map was calculated with the phase from Rab7 molecule only. 
The figure was produced by POVScript (Fenn et al., 2003) and Raster3D (Merritt and 
Bacon, 1997). b. Ribbon diagram of the Rab7-RILPe complex. Two Rab7 molecules 
a and c are colored lightgreen whereas two RILPe molecules b and d are red and 
darkgreen, respectively. The switch I, interswitch and switch II regions are colored 
cyan, royal blue and magenta, respectively. GTP molecules are shown as stick models 
and Mg2+ as a grey sphere. Residues 175-185 are shown in orange. (c) Top view of 
the Rab7-RILPe complex. The molecules are rotated by 90° along a horizontal axis 
relative to the view in (b). d. Comparison of Rab7-GTP in a free form and in complex 
with RILPe. Free Rab7-GTP (left panel) and that in complex with RILPe (right panel) 
are colored white and light green respectively.  Helix α5 of Rab7 is highlighted in red. 
The coloring scheme for the switch regions, GTP, Mg2+ and residues 175-185 of Rab7 








 (Figure 4-2b and 4-2c).  In this complex, one RILPe molecule interacts with its 
rystallographic 2-fold symmetry related counterpart to form a four-helix homodimer 
in which both helices α1 and α2 are involved in dimerization.  This homodimer binds 
two separate Rab7-GTP molecules on opposite sides with both helices involved in the 
interaction with Rab7. In the complex interface, although each Rab7-GTP interacts 
with both helices of RILPe, these two helices are contributed by two different 
molecules with helix α1 coming from one protomer whereas the helix α2 is from the 
other protomer.   
  
.1.4 Rab7-RILP interaction 
entical Rab7-RILPe interfaces 
as-like small GTPases complexed with their effectors, and the N-terminal half of the 
elix α1 and the C-terminus of the helix α2 of RILPe (Figure 4-3a). Most residues 
volved in these interactions are highly conserved among members of the Rab7 
bfamily. K38 (K82 in Rab34), a conserved residue in Rab7 and Rab34 (Figure 4-4a) 
 the switch I region which has been shown to be essential for the interaction of 
Rab34 with RILP (Wang et al., 2002), makes van der Waals contacts with E247d and 
Q250d. The invariant hydrophobic triad (residues F45, W62 and F77) (Figure 4-4a), 
c
4
In the structure of the complex, there are two id
(Figure 4-2b and 4-2c). For simplicity, we only discuss the interface formed between 
the chain A of Rab7 molecules and the RILPe homodimer (referred to as chains B and 
D). Rab7-GTP and RILPe share an extensive interface with a buried accessible 
surface area of 2273Å2, most of which involves hydrophobic interactions with some 
additional hydrogen bonds.   
There are two distinct contact areas in the interface between Rab7 and RILPe.  








which has been implicated in effector binding for the Rab5 subfamily members 
(Merithew et al., 2001), makes extensive hydrophobic interactions with RILPe 
(Figure 4-3a). Phe45 makes hydrophobic contacts with the methylene groups of both 
K259b and N256b. I41 makes hydrophobic interactions with the side-chain of F248b 
while F70 makes van der Waals contacts with the side-chain of R245d. The methylene 
groups of both T47 and T58 in the interswitch region make contacts with the aromatic 
ring from F263b. The side-chains of W62 and L73 contact those of L306d and L252b, 
respectively, via hydrophobic interactions. Moreover, the side-chain of D44 is 
hydrogen-bonded to the NZ group of K259b and the NH2 group of R255b, respectively, 
2 forms a salt bridge with the NZ group of K304d.   
drophobic surface in RILPe, which is formed by the 
aliphati
while the hydroxyl group of D8
The second contact area consists of parts of the N- and C-terminal segments of 
Rab7 which correspond to two hypervariable regions referred to as RabSF1 and 
RabSF4, respectively, and the C-terminal half of both helix α1 and α2 of RILPe 
(Figure 4-3b). Residues L8, V180 and L182, combined with the methylene groups of 
T47 and T58 from the interswitch region described above, form a hydrophobic 
surface to interact with a hy
c group of K304d, and the side-chains of M305d, I301d, L264b and P263b. In 
the N-terminal region of Rab7, L8 makes multiple hydrophobic contacts with K304d, 
M305d, I301d and F263b, while the side-chain of K10 makes a hydrogen bond with the 
main-chain oxygen of K304d, and van der Waals interactions with the main-chains of 
both M305d and G307d. In the C-terminal segment of Rab7, the side-chain of V180 
contacts that of I301d and the methylene groups of K300d and K304d via hydrophobic 
interactions while L182 makes hydrophobic interactions with the aliphatic groups of 

















Figure 4-3.  RILP-RILP and Rab7-RILP interfaces. 
a. Stereo diagram of the first Rab7-RILP interface between the switch and interswitch 
regions of Rab7 and RILPe. The coloring scheme for the switch and interswitch, and 
RILPe molecules is as in Figure 4-2b, and the rest of Rab7 is yellow.  
b. Stereo diagram of the second Rab7-RILP interface between the N- and C-terminal 
regions of Rab7 and RILPe.  The N- and C-terminal regions of Rab7 are blue and 
magenta, respectively with the rest of Rab7 in yellow. The coloring scheme for RILPe 
is as in (a). c. The RILP-RILP interface showing the interactions of two long helices 
α1 from chain b (red) and d (darkgreen), respectively. For simplicity, only pair-wise 
located residues involved in dimer interface are shown as stick models. d. The RILP-
RILP interface showing the interactions of the long helix α1 from chain b and the 
short helix α2 from chain d.  The coloring scheme is as in (c). All residues involved in











Figure 4-4.  Sequence alignment of Rab proteins, and the Rab7 binding domain 
of RILP with RILP-like proteins (RLPs). 
a. Sequence alignment of human Rab7, yeast Ypt7p, human Rab34, human Rab3a and 
human Rab5c. The secondary structures of human Rab7 in complex with RILPe are 
shown at the top. Switch and interswitch regions are marked with blue and green lines, 
respectively. RabSF motifs are marked with red lines. Mutated residues involved in 
teraction with RILP are marked with “#”. in
mouse RLP1 and hum
b. Sequence alignment of human RILP, 
an RLP2. The secondary structures of RILPe are shown at the 
top. Mutated residues involved in RILP dimerization are marked with “*” and those 
involved in interactions with Rab7 are marked with “ ”. Residues shown in Figure 4-
3c in positions a and d of the coiled-coil helix α1 are marked with black and red 
triangles, respectively.  
These figures were produced by ENDscript (Gouet et al., 2002). 
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formed by the side-chains of L264b, E267b, E268b, V294d, Q297d, R298d and I301d 
and makes multiple hydrophobic contacts with these residues. 
 
 
4.1.5 RILP dimer interface  
   The structure shows that two RILPe molecules form a tight homodimer which 
is held together predominantly by the parallel long helices α1 (Figure 4-2b and 4-2c). 
In addition, the short helix α2 also interacts with the helix α1 from the symmetry-
related RILPe molecule. Thus, the four helices are hold together to form the dimer 
interface dominated mainly by extensive hydrophobic interactions with a buried 
accessible surface area of 3680Å2. 
   Two long helices α1 forming the core of the dimer interface is a typical short 
coiled-coil protein structure that consists of two identical strands of amino acid 
sequences that wrap around each other in a gradual left-handed superhelical manner 
(Figure 4-2b). The amino acid sequences in this coiled-coil structure are 
characterized by a heptad repeat denoted as a-b-c-d-e-f-g, in which the hydrophobic 
residues are generally located at positions a and d (O'Shea et al., 1991) (Figure 4-4b)
here are four heptad repeats in the coiled-coil region of RILPe dimer. All residues at 
. 
T
the positions a and d except R255 are hydrophobic in nature. Two sets of pairwised 
residues (F248, I251, R255, L258, V262, L265, L269, F272, and L276) contact with 
each other to form the core of the dimer interface (Figure 4-3c).  The spatial 
arrangements of these residues in the dimer interface are quite similar to those 
observed in the leucine zipper motif (O'Shea et al., 1991).  The helix α2 also 
contributes to the dimerization of RILPe with its C-terminal segment contacting that 
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of the helix α1 from the symmetry-related RILPe molecule via predominantly 
hydrophobic interactions (Figure 4-3d).  
The homodimerization of RILPe was verified by deletion mutations and yeast 
o-hybrid interaction studies performed by collaborators (Figure 4-5a). Both 
hich contain the intact helices α1 and α2, can interact 
the interaction with RILP and its late endosomal/lysosomal targeting (Figures 4-5c  
tw
RILP199-401 and RILP241-310, w
with itself well. Deletion of the C-terminal segment of helix α2 in RILP241-294 affected 
neither its self-interaction nor its interaction with RILP241-310. However, RILP261-310, a 
construct with the N-terminal half of helix α1 deleted, abolished its self-interaction 
and interactions with RILP241-310. These results suggest that the N-terminal half of 




4.1.6 Mutagenesis and cellular localization 
To examine the role of residues involved in the formation of the RILPe 
homodimer and in the interfaces between Rab7-GTP and RILPe homodimer, Rab7 
and RILP variants were created by site-directed mutagenesis by collaborators. The 
resulting mutant Rab7 and RILP proteins were examined for their roles in the Rab7-
RILP interaction and/or RILP self-interaction by the yeast two-hybrid assays. The 
cellular localization of these mutants was also examined by immunofluorescence 
microscopy in HeLa cells expressing these mutants. Mutation of L8 to Ala (L8A) in 
Rab7 disrupted the binding of Rab7 to RILP (Figures 4-5c), and substantially reduced 
its late endosomal/lysosomal targeting while removal of the N-terminal 10 residues 





Figure 4-5. Effects of mutations on RILP dimerization and Rab7-RILP 
interaction. a. RILP forms a homodimer via self-interaction in a manner that is 
full-length RILP. b. Effects of Ala point mutations of RILP on its dimerization. 
Rab7Q67L on its interaction with RILP. Rab7Q67L and E185A mutant serve as 
positive controls. Rab7∆N contains residues 11-207; Rab7∆C1 contains residues 1-
176; Rab7∆C2 contains residues 1-185. d. Effects of mutations of RILP on its 
controls. 
  
dependent of residues (241-260) in its coiled-coil region. WT (wild type) refers to 
L287A serves as a positive control. c. Effects of truncation or Ala point mutations in 






















igure 4-6.  Effects of mutations of Rab7 and RILP on their cellular localization 
. Representative site-directed mutants (panels e, g, i, k and m) or a truncated form 
∆N; panel c) of Rab7Q67L defective in interaction with RILP are mistargeted to 
e cytosol (and nucleus for F45A) (as revealed by GFP attached to the N-terminus of 
es marked by co-
xpressed RILP (panels d, f, h, j, l and n as revealed by myc-tag). EGFP-Rab7Q67L 
anel a) and myc-RILP (panel b) serve as the positive control. Bar, 20μm. 
. Representative mutants of RILP (panels c, e, g, i, k and m, revealed by myc-tag) 
efective in interaction with Rab7 are mistargeted to the cytosol and did not associate 
ith punctuate late endosomes/lysosomes marked by co-expressed EGFP-Rab7Q67L 
anels b, d, f, h, j, l and n, viewed by GFP). The fragment encompassing residues 
ted, but still can be efficiently recruited to 















241-310 of RILPe is peripherally distribu
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and 4-6a). Mutations of some residues in the C-terminal region of Rab7 also affected 
s binding to RILP and its cellular localization. Substitution of V180 with Ala 
(V180A) abolished the binding of Rab7 to RILP (Figure 4-5c) and dramatically 
reduced its co-localization with RILP in the clustered late endosomes/lysosomes 
(Figure 4-6a). Moreover, removal of residues 177-207 (Rab7∆C1) of Rab7 abolished 
its interaction with RILP whereas deletion of residues 186-207 (Rab7∆C2) had no 
effect on its interaction with RILP (Figure 4-5c). The C-terminal hypervariable 
region of Rab proteins has been shown to act as one of the main signals for subcelluar 
targeting (Chavrier et al., 1991; Stenmark et al., 1994; Ali et al., 2004). These results 
suggest that both RabSF1 and RabSF4 regions of Rab7 act together as the structural 
determinants for RILP binding and subcellular targeting. In support of these 
observations, residues 19-22 of the RabCDR (RabSF1) of Rab3a have been found to 
be essential for Rab3a-Rabphilin3a complex formation (Ostermeier et al., 1999). 
Consistent with a role of switch and interswitch regions, Ala substitutions of D44, 
F45, and D82 of Rab7 also disrupted its interaction with RILP and reduced 
substantially or abolished its targeting to the clustered late endosomes/lysosomes 
 RLPs (RILP-like proteins) in regulation of lysosomal 
it
marked by co-overexpressed RILP (Figures 4-5c and 4-6a).  
Collaborators also mutated residues of RILP which are predicted to participate 
in Rab7 interactions. Mutations of L252, K304, M305 and L306 of RILP to Ala 
abrogated its interaction with Rab7 and these mutants failed to co-localize with Rab7 
in late endosomes/lysosomes (Figures 4-5d and 4-6b). Moreover, deletion of 
residues 295-306 in the C-terminal half of helix α2 led to defects in late 
endosomal/lysosomal targeting (Figure 4-6b). Since K304, M305 and L306 are 
located in a 62-residue unique region of RILP (residues 272-333) which has been 
shown to distinguish it from
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morphology and interactions with Rab7 (Wang et al, 2004), these observations 
confirm the previous results and explain why RILP rather than RLPs can interact with 
Rab7 and regulate lysosomal morphology. Collectively, these results suggest that the 
specific interactions between Rab7 and RILPe are essential for the targeting of Rab7 
and RILP to late endosomes/lysosomes. 
The extensive dimer interface of RILPe and the existence of such a dimer in 
vitro and in vivo suggest that dimerized RILPe may function as a structural unit for 
interaction with Rab7.  Residues, which are located in the core of RILPe dimer 
interface, were mutated. Consistent with the observation that the N-terminal half of 
the helix α1 is essential for RILP dimerization (Figure 4-5a), Ala substitutions of 
I251 and R255 (I251A and R255A) abolished both the dimerization of RILPe and 
targeting to late endosomes/lysosomes (Figures 4-5b and 4-6b) while mutation of 
L258 to Ala (L258A) reduced dramatically the self-interaction of RILPe, and 
substantially reduced late endosomal/lysosomal targeting (Figures 4-5b and 4-6b). 
Moreover, mutations of I251 and R255 to Ala abolished the interaction of RILP with 
Rab7, while substitution of L258 for Ala substantially reduced its binding to Rab7 
(Figure 4-5d).  Residues I251, R255, and L258 make no direct contacts with Rab7-
GTP, but substitutions of these residues with Ala still abolished or dramatically 
reduced the interaction with Rab7 and targeting of RILP to late endosomes/lysosomes. 
These results suggest that mutations disrupting the RILPe dimerization also abolish 
indirectly its interaction with Rab7-GTP and its late endosomal/lysosomal targeting. 
Combined with the observation that the Rab7 binding domain of RILP exists as a 
homodimer, these results suggest that the dimerized Rab7 binding domain of RILP is 
the structural and functional unit for interaction with two Rab7 molecules.  In this 
structural unit, helix α1 is essential for both dimerization and late 
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endosomal/lysosomal targeting, whereas the helix α2 is dispensable for dimerization 
but is absolutely required for late endosomal/lysosomal targeting.  
 
 
4.1.7 Structural diversity of Rab-effector recognition 
Numerous studies have established that Rab proteins are distributed in distinct 
intracellular compartments and function in concert with multiple effectors to regulate 
transport between organelles (Zerial et al., 2001). One important issue about the Rab-
effector interaction is how the GTP-bound form of the Rab protein recognizes its 
effectors specifically. To understand the structural basis of the Rab-effector 
recognition in general, the crystal structures of the Rab7-RILPe complex, the Rab3a-
Rabphlin-3a complex (Ostermeier et al., 1999), and the recently reported Rab5-
Rabaptin5 complex are compared (Zhu et al., 2004; Eathiraj et al., 2005). Comparison 
of these complexes revealed some similarities as well as differences. Although in 
these complexes, Rab molecules interact with their respective effectors using the 
relative conserved switch and interswitch regions, the overall binding modes of these 
complexes are markedly different (Figure 4-7).  First, Rabphilin3a does not form a 
homodimer whereas the effector domains of both Rabaptin5 and RILP form a 
homodimer for interaction with two Rab molecules. Second, only the switch and 
interswitch regions of Rab5 in the Rab5-Rabaptin5 complex are involved in the 
interactions with the effector domain of Rabaptin5 in a manner similar to those 
observed in Arf family. However, RabSF1 and RabSF4 of Rab7, and RabSF1, 
RabSF3 and RabSF4 of Rab3a are also involved in the interactions with their 
respective effector molecules. The fact that the RabSF1 region of Rab7 is absolutely 
important for interaction with RILP and its late endosomal/lysosomal targeting, 
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suggests that this region plays a determining role in the interaction with RILP.  
Moreover, although in these complexes, the effector molecules contact their 
respective Rab proteins using two antiparallel helices, the specific recognition 
between Rab proteins and their effectors is achieved in a remarkably different way 
terminal segment of the long 
helix o
formed by the RabSF1 and RabSF4 of Rab7 is involved in the effector binding 
(Figures 4-2d and 4-7). The structural diversity of Rab-effector recognition and the 
involvement of the RabSF motifs of Rab7 and Rab3a in effector binding suggest that 
each Rab protein interacts with its effector in a highly specific manner, presumably 
using the combination of the RabSF motifs in addition to the switch mechanism 
which is conserved for all small GTPases. 
 
(Figure 4-7).  In the Rab3a-Rabphilin3a complex, the N-
f Rabphilin3a contacts the switch and interswitch regions of Rab3a while the 
C-terminal helix and the adjacent SGAWFF structural element of Rabphilin3a fit into 
a hydrophobic pocket formed by RabSF1, RabSF3, RabSF4 and loop α2-β4 
(Ostermeier et al., 1999).  In the Rab5-Rabaptin5 complex, the effector domain of 
Rabaptin5 contacts Rab5 using only the N-terminal long helices of both protomers in 
the centre of the homodimer with its C-terminal short helix playing no role in binding 
of Rab5 (Figure 4-7). The structure of the Rab7-RILPe complex (Figures 4-2b and 
4-7) revealed that RILPe contacts Rab7 using the N-terminal long helix α1 of one 
protomer and the C-terminal short helix α2 of the other protomer.  Furthermore, both 
helices α1 and α2 of RILPe contact the RabSF1 and RabSF4 regions and the switch 
and interswitch regions with helix α1 contacting more with the switch and interswitch 
regions of Rab7, while the helix α2 making more interactions with RabSF1 and 










Figure 4-7. Structural comparison of the Rab-effector complexes. The regions of 
N and C termini of GTPases and their effectors are labeled.  






The structure of Rab7-GTP was determined first, showing that the overall fold 
f Rab7-GTP is similar to those of other Rab proteins with bound GTP except that the 
itch II region adopted an extended-loop structure. The reason why the switch II 
gion adopted this unusual structure is not known, presumably due to the orientation 
of F77 in the switch II region.  Comparison of Rab7-GTP alone and in complex with 
RILP showed that the N- and C-terminal segments of the Rab7 undergo significant 
comformaional changes upon binding to RILP.  These conformational changes may 
have important functional implications in RILP binding.  
Structure of the Rab7-GTP in complex with the Rab7 binding domain of RILP 
shows that Rab7-GTP interacts with RILPe in a highly specific manner with the 
switch and interswitch regions conferring the main binding affinity and the RabSF1 
and RabSF4 motifs providing the additional affinities that are absolutely required for 
the interaction measured by yeast two-hybrid assays.  Structural and mutational 
studies explain why Rab7 but not other Rab proteins interact with RILPe since some 
key residues of Rab7 involved in RILPe binding are unique to Rab7 proteins across 
species but not in other Rab proteins (Figure 4-4a).  Moreover, the fact that the helix 
α2 of RILPe interacts specifically with the RabSF1 and RabSF4 regions of Rab7 
ed the earlier studies on RILP, showing that a unique region of RILP 
orphology and interactions with Rab7 and Rab34 (Wang et al., 2004).  Sequence 
omparison between Rab7 and Rab34 showed that most residues of Rab7 involved in 
interactions with RILP are conserved in Rab34 (Figure 4-4a). This observation 










In the Rab7-RILPe complex, RILPe forms a homodimer which acts as a 
structur
e long helix α1 from one 
protom
to 
be a common characteristic for all small GTPases (Hanzal-Bayer et al., 2002; Shiba et 
al and functional unit that creates two symmetric surfaces on the two opposite 
sides of the dimer to interact with two separate Rab7-GTP molecules. The mode of 
action of RILPe dimer in Rab7 binding is a reminiscent of GRIP domain in Arl1 
binding (Panic et al., 2003a) but with markedly different binding mode in several 
details (Figure 4-7).  First, all three helices of GRIP domain are indispensable for 
dimerization whereas only the long helix α1 of RILPe is essential for dimerization. 
Second, GRIP domain interacts with Arl1 using its first two helices (α1and α2) from 
the same protomer while RILPe contacts Rab7 using th
er and the short helix α2 from the other protomer. Third, GRIP domain 
interacts predominantly with the switch II region of Arl1, while RILPe contacts not 
only the switch and interswitch regions but also the RabSF1 and RabSF4 regions of 
Rab7. So far, three small GTPases in complex with their effectors, the Rab7-RILP 
complex, the Arl1-GRIP complex (Panic et al., 2003a) and the Rab5-Rabaptin5 
complex (Zhu et al., 2004) exhibit a dyad-symmetric binding mode. For Golgin-245 
and Rabaptin5, the dimerization of the C-terminal domain may facilitate their 
anchoring on the membrane.  However, the Rab7 binding domain of RILP is located 
in the middle of its sequence. Although RILPe dimerization is necessary for 
interaction with Rab7 as well as for its membrane targeting, the significance for its 
Rab7-binding domain being positioned in the middle of the molecule remains to be 
examined.   
Structural comparison of three Rab-effector complexes revealed some 
common features of effector binding with some striking differences as well.  The use 




ele-Mortimer et al., 1994; Ostermeier et al., 1999). The observation that 
only th
3; Panic et al., 2003a). These GTPases use their switch mechanism to sense 
the state of the bound nucleotide, thereby binding to their respective effectors or 
regulators.  For example, Rab7 in GDP-bound form binds to REP-1 (Rak et al., 2004) 
while in GTP-bound form it binds to RILPe using the common switch and interswitch 
regions. Rab proteins constitute a unique family of small GTPase in terms of their 
diverse roles in membrane trafficking and the heterogeneity of their interaction with 
effectors.  The crystal structure of Rab3a-Rabphilin3a (Ostermeier et al., 1999) 
revealed for the first time that Rab3A, unlike other Ras-like small GTPases, interacts 
with its effector using combination of its switch mechanism and its RabCDRs, and led 
to a conclusion that RabCDRs are probably the key determinants for the regulation of 
vesicle traffic. The structure of Rab7-RILPe complex supports this conclusion by 
revealing that RabCDRs (RabSF1 and RabSF4) of Rab7 are additional and required 
structural determinants for effector binding. Although RabSF3 (α3-β5 loop) has been 
shown to be involved in the specific interaction with Rabphilin3a (Ostermeier et al., 
1999), it does not contribute to the Rab7-RILP interaction. These observations 
suggest that the α3-β5 loop may be just specific to Rab3a subfamily and not a general 
structural determinant for effector binding, despite the finding that α3-β5 loop is 
important for the function of other Rab proteins including Ypt1p, and Rab5 
(Brennwald et al., 1993; Stenmark et al., 1994).  Instead, the RabSF1 and RabSF4 
motifs of Rab GTPases play more important roles in effector recognition (Chavrier et 
al., 1991; Ste
e switch and interswitch regions of Rab5 are involved in Rabaptin5 binding is 
probably not due to the truncation of the C-terminal end of Rab5 used for 
crystallization (Zhu et al., 2004) as the full-length and C-terminal truncated Rab5 bind 
equally well to the N terminus of early endosome antigen 1 (Merithew et al., 2003). 
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Additional Rab5-Rabaptin5 interactions might exist as the N-terminus of Rab5 has 
been suggested to be a structural determinant for effector binding (Stenmark et al., 
1994). In Rab7-RILPe structure, upon RILPe binding, the C-terminal region of Rab7 
undergoes a strikingly structural transition and part of the helix α5 transforms into a 
β-sheet with the extended N-terminus, thereby interacting with RILP (Figure 4-2). 
The involvement of the RabSF motifs, particularly the N- and C-terminal RabSFs, 
may be a general feature for most Rab-effector interaction. The combination of the 
RabSFs with the conserved switch and interswitch regions allows Rab proteins to bind 
a wide range of effectors in a specific manner and participate in distinct trafficking 
pathways.  
In conclusion, the results presented here show that Rab7-GTP interacts with 
the Rab7 binding domain of RILP with high specificity, and disrupting these 
interactions abolishes late endosomal/lysosomal targeting for both Rab7 and RILP. 
Similar to the GRIP domain of Golgin-245, the Rab7 binding domain of RILP forms a 
homodimer, which serves as a structural and functional unit for Rab7 binding, 
thereafter membrane targeting. This conclusion raises an intriguing possibility that 
Rab7 and RILP are targeted simultaneously to the membrane as Rab7-RILP2-Rab7 
complex. With regard to membrane targeting, Rab7 and RILP may influence each 
other, rather than one regulates the other. The combined use of the switch and 
interswitch regions with the RabSF1 and RabSF4 motifs for effector binding as shown 
here for Rab7 and Rab3A (Ostermeier et al., 1999) may be a general mode of action 
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